RESOURCES


home.aspx
   
Cell Growth Performance In Single-Use Bags CELL GROWTH PERFORMANCE IN SINGLE-USE BAGS

whitepaper

Mar 15, 2019

Achieving consistent cell growth is critically important to the biotech industry. To optimize the final drug product output the current industry trends are towards higher cell densities and protein titers. With the uptake of single-use bags in cell c...

Read More

More Efficient Bispecific Antibody Purification With Fewer Steps MORE EFFICIENT BISPECIFIC ANTIBODY PURIFICATION WITH FEWER STEPS

whitepaper

Feb 28, 2019

A single-step downstream process using protein A chromatography to purify a bispecific antibody (BsAb) in early screening has been successfully developed to replace an existing-three step process. The goal was to separate BsAb monomer from fragments ...

Read More

BEST for QC Microbiology Training BEST FOR QC MICROBIOLOGY TRAINING

whitepaper

Feb 27, 2019

Bioburden testing is critical for monitoring water quality and raw materials and for ensuring that manufacturing processes remain in microbiological control. During the first day of the training, you will learn about Advantages and limitations of mem...

Read More

Digital Twins in Healthcare DIGITAL TWINS IN HEALTHCARE

whitepaper

Feb 21, 2019

In this paper, you will learn how far we have come in generating massive amounts of patient data, but how unprepared we are to make use of it. A digital twin promises an outcome-driven approach to handling the data deluge arising from the patient&rsq...

Read More

Digital Manufacturing Of Biologics DIGITAL MANUFACTURING OF BIOLOGICS

whitepaper

Feb 19, 2019

The digital revolution in manufacturing began with an explosion in monitoring, analytics, and new computing capabilities. Combined with advances such as artificial intelligence (AI), automation, and robotics, digital is changing manufacturing concept...

Read More

Fostering Innovation in Healthcare FOSTERING INNOVATION IN HEALTHCARE

whitepaper

Feb 18, 2019

In order to compete in today’s challenging healthcare landscape, health systems must leverage new and innovative models of care delivery. The U.S. Advisory Committee on Measuring Innovation in the 21st Century Economy defines innovation as &ldq...

Read More

Screening for Disease Markers Using Non-Invasive Breath Gas Analysis SCREENING FOR DISEASE MARKERS USING NON-INVASIVE BREATH GAS ANALYSIS

whitepaper

Feb 18, 2019

Over the last few years, a developing field of research has emerged in breath gas analysis of volatile organic compounds (VOCs). This technique is non-invasive and has a number of possible applications, including monitoring of metabolic processes, th...

Read More

Cell Therapy Logistics CELL THERAPY LOGISTICS

whitepaper

Feb 11, 2019

Much of the discussion in the cell therapy industry today focuses on the complexity of manufacturing and the unique characteristics of each dose. However, the ultimate success of a cell therapy clinical trial rests on the ability to deliver a viable,...

Read More

Optimizing Process Efficiency In Upstream Manufacturing OPTIMIZING PROCESS EFFICIENCY IN UPSTREAM MANUFACTURING

whitepaper

Feb 08, 2019

Process efficiency is a key goal for biopharmaceutical production, focused on increasing the process' speed, keeping costs under control, and building flexibility into the process, all while maintaining the quality of the final product. In this a...

Read More

Upstream Bioprocessing In Food And Feed Applications UPSTREAM BIOPROCESSING IN FOOD AND FEED APPLICATIONS

whitepaper

Feb 05, 2019

Mix water and flour with a little yeast and incubate the dough in a warm place until its volume has approximately doubled“ – such household baking instructions will (or may not) produce a decent result, but are not what is needed in the i...

Read More

The Spectacular World of Cancer Cell Imaging THE SPECTACULAR WORLD OF CANCER CELL IMAGING

whitepaper

Feb 05, 2019

Advances in imaging techniques have been instrumental in many aspects of cancer research; from screening and diagnosis to the guidance of cancer treatments and the monitoring of its recurrence. Insights provided by these advanced imaging techniques h...

Read More

Achieving Competitive Advantage With Anatomy And Physiology ACHIEVING COMPETITIVE ADVANTAGE WITH ANATOMY AND PHYSIOLOGY

whitepaper

Feb 04, 2019

This whitepaper explores how best in class anatomy, physiology and clinical content, images, and customized solutions enable organizations to achieve strong competitive advantage, drive credibility, productivity and differentiation. We will share ide...

Read More

Analyses of Large Proteins, Antibodies, and Modified Proteins Using A New Series of Advanced Large Pore HPLC Materials ANALYSES OF LARGE PROTEINS, ANTIBODIES, AND MODIFIED PROTEINS USING A NEW SERIES OF ADVANCED LARGE PORE HPLC MATERIALS

whitepaper

Jan 23, 2019

As pharmaceutical companies have shifted their development focus to large-molecule biotherapeutics, the ability to separate intact monoclonal antibodies and antibody-drug conjugates for characterization purposes have become extremely important. To en...

Read More

Live-cell Analysis for Neuroscientists LIVE-CELL ANALYSIS FOR NEUROSCIENTISTS

whitepaper

Jan 18, 2019

Stem cell technologies using iPSCs allow researchers to create differentiated neurons and support cells to study the human brain and nervous system functions, circumventing several challenges in neurobiology research. These technologies, however, req...

Read More

Cell Biology and Cancer CELL BIOLOGY AND CANCER

whitepaper

Jan 18, 2019

We now understand a lot about cancer. We know that it results from a series of genetic changes having to do with cell division and growth control and genetic instability, mortality, the suicide mechanism in cells; the ability of the cells to migrate;...

Read More

How to Increase the Solubility and Bioavailable with Hot Melt Extrusion? HOW TO INCREASE THE SOLUBILITY AND BIOAVAILABLE WITH HOT MELT EXTRUSION?

whitepaper

Jan 12, 2019

Hot Melt Extrusion (HME) is an enabling processing technology that dates back many decades in the plastics, food, and other industries, and has been applied in pharmaceuticals for nearly 30 years now. Pharmaceutical manufacturers choose HME to enable...

Read More

Maximizing Throughput for Shotgun Proteomics MAXIMIZING THROUGHPUT FOR SHOTGUN PROTEOMICS

whitepaper

Jan 12, 2019

The proteome of an organism is a dynamic entity that encompasses all expressed proteins including isoforms and modifications as well as protein-protein interactions. It has taken decades to hone the analytical methods required to measure and quantify...

Read More

Why digital transformation is redefining how people, technology and devices interact in healthcare WHY DIGITAL TRANSFORMATION IS REDEFINING HOW PEOPLE, TECHNOLOGY AND DEVICES INTERACT IN HEALTHCARE

whitepaper

Jan 11, 2019

Technology touches almost every aspect of healthcare today, from how doctors interact with patients, to the way medical data is accessed and used, to the role of robotics in surgery. New technology, such as wearable devices, smartly connected implant...

Read More

Introduction to Machine Learning in Healthcare INTRODUCTION TO MACHINE LEARNING IN HEALTHCARE

whitepaper

Jan 10, 2019

15 minutes. That’s how long your doctor has to see you, assess your complaint, diagnose a solution and see you out the door – hopefully on the pathway back to wellness. This isn’t much time when you consider the wealth of informatio...

Read More

Horizons in HIV Drug Development – What’s Past is Prologue HORIZONS IN HIV DRUG DEVELOPMENT – WHAT’S PAST IS PROLOGUE

whitepaper

Jan 07, 2019

To better predict the future of HIV pharmaceuticals, we must understand the past – that’s the premise behind Horizons in HIV Drug Development – What’s Past is Prologue, the free whitepaper from Citeline, part of the Informa Ph...

Read More

Application of CRISPR/Cas to the Generation of  Genetically Engineered Mice APPLICATION OF CRISPR/CAS TO THE GENERATION OF GENETICALLY ENGINEERED MICE

whitepaper

Jan 07, 2019

Genetically engineered mice are invaluable tools for the in vivo study of gene function. The use of gene modification methods, both in embryonic stem (ES) cells and in the embryo, to modify the mouse genome has provided valuable insights into human d...

Read More

Food safety and quality culture FOOD SAFETY AND QUALITY CULTURE

whitepaper

Jan 03, 2019

How to improve food safety culture? Food safety culture is a major component of food safety management systems, including ISO 22000, FSSC 22000 and BRC Food Safety Issue 8. Demonstrating improvement in food safety and quality culture is a major compo...

Read More

Beyond Adherence to Optimal Medication Management BEYOND ADHERENCE TO OPTIMAL MEDICATION MANAGEMENT

whitepaper

Jan 02, 2019

Clinicians generally cite medication nonadherence as the primary reason patients don’t achieve treatment goals or optimal outcomes or gain control of their chronic conditions. This assertion is supported by the following data. It’s also w...

Read More

Cancer Research Current Trends & Future Directions CANCER RESEARCH CURRENT TRENDS & FUTURE DIRECTIONS

whitepaper

Jan 02, 2019

Throughout history, the progress of humankind can be measured by the achievements and milestones of each generation’s new knowledge discoveries and their applications. Scientists, engineers, and inventors’ contributions have impacted and ...

Read More

Using Analytics, Machine Learning, and Simulation Technology to BETTER MANAGE PATIENT FLOW USING ANALYTICS, MACHINE LEARNING, AND SIMULATION TECHNOLOGY TO BETTER MANAGE PATIENT FLOW

whitepaper

Dec 27, 2018

MANAGING PATIENT FLOW is a growing and complex challenge for hospitals and healthcare systems of all sizes. Poor patient flow planning creates waits and delays that frustrate patients and practitioners alike, diminishes the quality of care, wastes me...

Read More

Finding High Producing Clones with Monoclonality Assurance in One Day FINDING HIGH PRODUCING CLONES WITH MONOCLONALITY ASSURANCE IN ONE DAY

whitepaper

Dec 21, 2018

In the discovery and development of novel biopharmaceuticals (such as antibodies) for therapeutic use Cell Line Development is an integral process in the biomanufacturing of therapeutic proteins. Mammalian cells make ideal factories for protein produ...

Read More

The Insight-Driven Health Plan THE INSIGHT-DRIVEN HEALTH PLAN

whitepaper

Dec 20, 2018

In the rapidly growing Medicare Advantage market, mid-sized regional health plans must work smarter with data to compete against the major national players. Success in acquiring, retaining, and engaging members increasingly depends on deep and timely...

Read More

The Road to Healthcare Value Is Driven by Quality Workforce Integration THE ROAD TO HEALTHCARE VALUE IS DRIVEN BY QUALITY WORKFORCE INTEGRATION

whitepaper

Dec 20, 2018

Regardless of different structures, geographies and populations served, organizations who become leaders in the future healthcare value economy will employ quality as a growth strategy. They will tie their success to it. In this paper, NAHQ and ACLC ...

Read More

Monitoring receptor ligand binding in living cells MONITORING RECEPTOR LIGAND BINDING IN LIVING CELLS

whitepaper

Dec 17, 2018

A number of assay techniques are used to study ligand binding to GPCRs in living cells. The most well-known being the use of radioactively labelled ligands which unfortunately, is labor intensive, needs dedicated equipment and has disposal and safety...

Read More

Patient-Centered Care in Type 2 Diabetes Mellitus PATIENT-CENTERED CARE IN TYPE 2 DIABETES MELLITUS

whitepaper

Dec 14, 2018

There have been many advancements in pharmacologic agents for the treatment of type 2 diabetes mellitus (T2DM) during the past 3 decades. At the same time, evidence in support of interventional approaches, the relationship between clinical parameters...

Read More

Is Your Biologic At Risk For Delays, Disruptions Or Audits? IS YOUR BIOLOGIC AT RISK FOR DELAYS, DISRUPTIONS OR AUDITS?

whitepaper

Dec 13, 2018

Thus, it’s no surprise that the world’s largest pharmaceutical companies have invested a combined $1.5 billion over the past five years to focus primarily on the advance of new biologics and biosimilars. While the North American economy r...

Read More

Living with Cancer LIVING WITH CANCER

whitepaper

Dec 13, 2018

Living with cancer is about dealing with the unknown. It is about trying to grasp the news and starting to understand its life-changing effect. It is about wondering if the treatment is working and whether the side effects will go away soon. It is ab...

Read More

Navigating Patient Payment Conversations with Financial Counseling NAVIGATING PATIENT PAYMENT CONVERSATIONS WITH FINANCIAL COUNSELING

whitepaper

Dec 12, 2018

Many healthcare organizations depend on the work of financial counselors to help patients understand both their insurance coverage and their financial obligations. These professionals help patients make smart choices by answering questions about the ...

Read More

An Innovative Approach to Manufacturing Biologics Using Microbial Fermentation AN INNOVATIVE APPROACH TO MANUFACTURING BIOLOGICS USING MICROBIAL FERMENTATION

whitepaper

Dec 12, 2018

The use of microbial fermentation to make biologics is growing rapidly. A manufacturing platform is an increasingly popular way to speed up process development stages and get a biologic to market faster. High-throughput systems can speed up the optim...

Read More

Cell Therapy Today - New Developments in Immunotherapy CELL THERAPY TODAY - NEW DEVELOPMENTS IN IMMUNOTHERAPY

whitepaper

Dec 06, 2018

PHCbi brand Cell-IQ™ CO2 and O2 incubators are designed to deliver reproducibility critical to immunotherapy and regenerative medicine from one day to the next. Your desired temperature and gas concentrations replicate the in vivo model of any ...

Read More

Rare Disease Landscape: Will the Blockbuster Model Be Replaced? RARE DISEASE LANDSCAPE: WILL THE BLOCKBUSTER MODEL BE REPLACED?

whitepaper

Dec 02, 2018

With the ‘blockbuster bubble’ seemingly burst and patent protection giving way to huge rises in generic competition, the pharma industry appears to be focusing on high-value drugs for rare diseases of low prevalence for which there is a p...

Read More

Advanced Therapeutic Antibody Discovery with Multiplexed Screening ADVANCED THERAPEUTIC ANTIBODY DISCOVERY WITH MULTIPLEXED SCREENING

whitepaper

Nov 25, 2018

Antibody-based therapeutics is the fastest growing and most successful therapeutic modality for treating numerous diseases including cancer, autoimmune disorders, and infectious disease. Multiplexed high throughput screening has become an essential c...

Read More

EPR – The ‘Workhorse Technique’ That is Still Enabling Scientists to Break New Ground After 70+ Years EPR – THE ‘WORKHORSE TECHNIQUE’ THAT IS STILL ENABLING SCIENTISTS TO BREAK NEW GROUND AFTER 70+ YEARS

whitepaper

Nov 25, 2018

A surprisingly large number of materials have unpaired electrons. These include free radicals, many transition metal ions, and defects in materials. Free radicals are often short-lived, but play crucial roles in many significant processes such as pho...

Read More

RADIOTHERAPY: seizing the opportunity in cancer care RADIOTHERAPY: SEIZING THE OPPORTUNITY IN CANCER CARE

whitepaper

Nov 22, 2018

The incidence of cancer is increasing, resulting in a rising demand for high‑quality cancer care. In 2018, there were close to 4.23 million new cases of cancer in Europe, and this number is predicted to rise by almost a quarter to 5.2 million by 2040...

Read More

Convective forces increase CXCR4-dependent glioblastoma cell invasion in GL261 murine model CONVECTIVE FORCES INCREASE CXCR4-DEPENDENT GLIOBLASTOMA CELL INVASION IN GL261 MURINE MODEL

whitepaper

Nov 19, 2018

Glioblastoma is the most common and malignant form of brain cancer. Its invasive nature limits treatment efficacy and promotes inevitable recurrence. Previous in vitro studies showed that interstitial fluid flow, a factor characteristically increased...

Read More

GUIDE TO CANCER EARLY DIAGNOSIS GUIDE TO CANCER EARLY DIAGNOSIS

whitepaper

Nov 19, 2018

Under the terms of this license, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any spe...

Read More

How cloud analytics and visualization are transforming Healthcare and Life Sciences HOW CLOUD ANALYTICS AND VISUALIZATION ARE TRANSFORMING HEALTHCARE AND LIFE SCIENCES

whitepaper

Nov 18, 2018

Healthcare and Life Sciences organizations are rapidly adopting robust data visualization and analytics capabilities. Hospitals and other healthcare providers are using analytics to identify opportunities for improvement in patient care and operation...

Read More

Emerging Liability Risks: Legionellosis EMERGING LIABILITY RISKS: LEGIONELLOSIS

whitepaper

Nov 17, 2018

Legionellosis – a bacterial infection that can cause symptoms ranging from mild flu to a deadly strain of Legionnaires’ disease (LD) – is fast emerging as a serious threat to the public and businesses. This risk bulletin reviews the...

Read More

Using Integrated Technologies to Solve Today’s Nursing Challenges: a How-to Guide for Nurse Leaders USING INTEGRATED TECHNOLOGIES TO SOLVE TODAY’S NURSING CHALLENGES: A HOW-TO GUIDE FOR NURSE LEADERS

whitepaper

Nov 17, 2018

Integrated technologies have already begun to impact the discipline of nursing. Nurse leaders are positioned to influence how technology is applied in the patient care environment but many aren’t asking the critical questions that need to be as...

Read More

Cap Inspection Provides Criticalb Information for Lab Automation CAP INSPECTION PROVIDES CRITICALB INFORMATION FOR LAB AUTOMATION

whitepaper

Nov 17, 2018

Cost containment in the healthcare system has placed clinical laboratories under constant pressure to improve efficiency while addressing patient care and safety concerns. As part of the design process, today’s instrument manufacturers seek to ...

Read More

Accelerating Telehealth Adoption: Telemedicine’s Role in the Volume to Value Journey ACCELERATING TELEHEALTH ADOPTION: TELEMEDICINE’S ROLE IN THE VOLUME TO VALUE JOURNEY

whitepaper

Nov 16, 2018

There is growing evidence that telehealth expands access to care, improves health outcomes and healthcare quality, increases patient engagement, and reduces healthcare costs. Yet skeptics are concerned about increased utilization and lack of ROI. Thi...

Read More

Another Set of Eyes: Machine Vision Automation Solutions for In Vitro Diagnostics ANOTHER SET OF EYES: MACHINE VISION AUTOMATION SOLUTIONS FOR IN VITRO DIAGNOSTICS

whitepaper

Nov 16, 2018

Microscan at a Glance.In Vitro Diagnostics Market Introduction. Machine vision system development. Key Challenges. Lessons Learned

Read More

Efficient Removal of Aggregates from Monoclonal Antibodies EFFICIENT REMOVAL OF AGGREGATES FROM MONOCLONAL ANTIBODIES

whitepaper

Nov 16, 2018

Monoclonal antibody (mAb) therapeutics have been widely used to treat various diseases, including cancer. Oftentimes, dimers and other high molecular weight aggregates are present in the mAb therapeutics, leading to reduced biological activity. Tradi...

Read More

MicroRNA Expression Patterns Responsible for Inducing Chemo-Resistance in Ovarian Cancer MICRORNA EXPRESSION PATTERNS RESPONSIBLE FOR INDUCING CHEMO-RESISTANCE IN OVARIAN CANCER

whitepaper

Nov 15, 2018

Despite significant progress in our understanding of the pathophysiology of cancer as a whole, ovarian cancer still remains as one of the most intractable forms of the disease with only 30% cure rate with the conventional therapy. It is also one of m...

Read More

Titration and Data Integrity eBook TITRATION AND DATA INTEGRITY EBOOK

whitepaper

Nov 15, 2018

For laboratories that must comply with Good Laboratory Practices (GLP), Good Manufacturing Practices (GMP), and Good Automated Manufacturing Practices (GAMP) regulations, it is important to have records or documented evidence of all relevant analyses...

Read More

CARING FOR QUALITY IN HEALTH CARING FOR QUALITY IN HEALTH

whitepaper

Nov 14, 2018

This synthesis report draws on key lessons from the OECD Health Care Quality Review series. As health costs continue to climb, policymakers increasingly face the challenge of ensuring that substantial spending on health is delivering value for money....

Read More

Overview of Animal-Derived Cell Culture Technology OVERVIEW OF ANIMAL-DERIVED CELL CULTURE TECHNOLOGY

whitepaper

Nov 13, 2018

Cell culture has become an indispensable technology in many branches of the life sciences. It provides the basis for studying the regulation of cell proliferation, differentiation and product formation in carefully controlled conditions, with process...

Read More

Minimizing Sterile Filtration Risk Through Quality By Design MINIMIZING STERILE FILTRATION RISK THROUGH QUALITY BY DESIGN

whitepaper

Nov 13, 2018

Controlling bioburden throughout biomanufacturing processes is critical to assuring drug products are safe for human use. To ensure products are free from microbial contamination, multiple filtration steps are implemented across the biomanufacturing ...

Read More

New insight into the genetics, developmental mechanism and therapeutic targets of Retinitis Pigmentosa NEW INSIGHT INTO THE GENETICS, DEVELOPMENTAL MECHANISM AND THERAPEUTIC TARGETS OF RETINITIS PIGMENTOSA

whitepaper

Nov 12, 2018

Hereditary degeneration of the human retina is genetically miscellaneous, with more than a hundred genes identified until now. Retinitis pigmentosa (RP) is a group of genetic retinal disorder which results in the degeneration of rods & cones phot...

Read More

Healthcare Artificial Intelligence Value Proposition HEALTHCARE ARTIFICIAL INTELLIGENCE VALUE PROPOSITION

whitepaper

Nov 12, 2018

According to the Wall Street Journal, deep learning systems have a fatal flaw: there is no way to tell how a decision was made. CytoSavvy is a pathology informatics software company using artificial intelligence to attack the big data problem for dru...

Read More

Pharmaceutical Assay and Multicomponent Analysis using the LAMBDA 365 UV/Vis Spectrophotometer PHARMACEUTICAL ASSAY AND MULTICOMPONENT ANALYSIS USING THE LAMBDA 365 UV/VIS SPECTROPHOTOMETER

whitepaper

Nov 12, 2018

Combination drugs containing Paracetamol and Aspirin are widely used analgesics with anti-inflammatory properties for treatment of migraines. This application describes the efficient use of a UV/Vis instrument in determining the quantity of percent a...

Read More

Artificial Intelligence in Healthcare ARTIFICIAL INTELLIGENCE IN HEALTHCARE

whitepaper

Nov 12, 2018

Since the inception of electronic health record (EHR) systems, volumes of patient data have been collected, creating an atmosphere suitable for translating data into actionable intelligence. The growing field of artificial intelligence (AI) has creat...

Read More

Lean Manufacturing ofPolyurethane, Assisted by Near-infrared (NIR) andRaman Spectroscopy LEAN MANUFACTURING OFPOLYURETHANE, ASSISTED BY NEAR-INFRARED (NIR) ANDRAMAN SPECTROSCOPY

whitepaper

Nov 11, 2018

Chemical manufacturing such as polyurethane production is characterized by a cost-intensive production process combined with a negative ecological impact. These adverse effects can be significantly improved by using vibrational spectroscopy. This ana...

Read More

Medication Reconciliation: The Biggest Patient Safety Issue Facing Clinicians Today MEDICATION RECONCILIATION: THE BIGGEST PATIENT SAFETY ISSUE FACING CLINICIANS TODAY

whitepaper

Nov 11, 2018

Executive Summary: Medication reconciliation is one of the most significant challenges facing healthcare organizations today. An inaccurate medication history can follow a patient throughout every encounter during a hospital stay and beyond. Even sma...

Read More

Mortality Data in Healthcare Analytics MORTALITY DATA IN HEALTHCARE ANALYTICS

whitepaper

Nov 11, 2018

The incorporation of mortality data into healthcare data sets allows fraud prevention, accurate billing, and benefits distribution, and true outcome analysis (especially in fatal disease areas like oncology, where survival is a key endpoint). The net...

Read More

The Future of Electronic Health Records THE FUTURE OF ELECTRONIC HEALTH RECORDS

whitepaper

Nov 10, 2018

Ten years ago, one doctor in 10 kept digital records on their patients. The other 90 percent made notes on paper and stored them in manila folders on shelves and in filing cabinets. Paper records had some obvious disadvantages. They took up space, th...

Read More

How to Achieve Sub-Second Substructure Query Response Times HOW TO ACHIEVE SUB-SECOND SUBSTRUCTURE QUERY RESPONSE TIMES

whitepaper

Nov 06, 2018

Chemical substructure and similarity searching is the cornerstone of most cheminformatics systems and a critical feature in electronic lab notebooks. As the scale of cheminformatics systems has grown, users are often frustrated with the performance o...

Read More

An Editorial Mission: CRISPR Targets Animal Models AN EDITORIAL MISSION: CRISPR TARGETS ANIMAL MODELS

whitepaper

Nov 06, 2018

CRISPR genome-editing technology is only five years old, but it has already made remarkable strides in biomedical, microbial, and agricultural research. CRISPR affords scientists the ability to edit multiple genes at once in any extant organism, whic...

Read More

HEALTHCARE’S NEW INNOVATION AGENDA HEALTHCARE’S NEW INNOVATION AGENDA

whitepaper

Nov 05, 2018

Anecdotal evidence abounds: Healthcare systems report deploying artificial intelligence (AI) and machine learning tools to support clinical decision-making. Big Data and genomics have accelerated the arrival of precision medicine. And recruits from S...

Read More

An Introduction to CAR T-Cell Production AN INTRODUCTION TO CAR T-CELL PRODUCTION

whitepaper

Oct 23, 2018

Immunotherapy harnesses the components of an individual's own immune system to identify and attack cancer cells. One form of immunotherapy is adoptive cell transfer (ACT), where the patient's immune cells are collected, genetically modified, ...

Read More

Better Heart Health Whitepaper BETTER HEART HEALTH WHITEPAPER

whitepaper

Oct 22, 2018

In recognition of World Heart Day, September 29, 2018, Informa Pharma Intelligence would like to invite you to download our latest whitepaper, Better Heart Health with Mobile Apps? The Impact of Mobile Apps on Coronary Heart Disease in the US. This e...

Read More

Rheumatoid Arthritis - Old and New Approaches Shifting the Treatment Paradigm RHEUMATOID ARTHRITIS - OLD AND NEW APPROACHES SHIFTING THE TREATMENT PARADIGM

whitepaper

Oct 19, 2018

Download your copy of Rheumatoid Arthritis: Old and New Approaches Shifting the Treatment Paradigm. Access the contents of this essential whitepaper from Informa Pharma Intelligence and explore the current and future outlook for rheumatoid arthritis ...

Read More

Miniaturisation of an HTRF methyltransferase assay that detects histone modifying activity MINIATURISATION OF AN HTRF METHYLTRANSFERASE ASSAY THAT DETECTS HISTONE MODIFYING ACTIVITY

whitepaper

Oct 19, 2018

High throughput screening is mostly done in pharmaceutical companies that test whole libraries of compounds. Reducing the assay volume will reduce operating costs. At the same time, it is necessary to prove that the smaller volume will not have a neg...

Read More

THE BUSINESS VALUE OF IMPROVING PATIENT EXPERIENCE THE BUSINESS VALUE OF IMPROVING PATIENT EXPERIENCE

whitepaper

Oct 18, 2018

With the healthcare industry bowing to consumerization, consumers are expecting and demanding higher quality service from their providers. Retaining patients, particularly in the current age of healthcare consumerization, is becoming more difficult. ...

Read More

Patheon’s Solid and Sterile Dosage Forms Brochure PATHEON’S SOLID AND STERILE DOSAGE FORMS BROCHURE

whitepaper

Oct 15, 2018

By partnering with Patheon, you have access to a remarkable range of dosage form technologies for oral solids. Take advantage of our expansive scientific resources and expertise to create a product that stands out in the marketplace. For more informa...

Read More

Measuring the Impact of Pharmacy Customer Loyalty on Health System Utilization and Readmission Rates MEASURING THE IMPACT OF PHARMACY CUSTOMER LOYALTY ON HEALTH SYSTEM UTILIZATION AND READMISSION RATES

whitepaper

Oct 15, 2018

Quantifying the direct and indirect value that a business unit delivers to its parent health system has traditionally been difficult. In this case study, we discuss the impact of pharmacy customer loyalty on the Fairview Health Services system and we...

Read More

The growing role of human factors and usability engineering for medical devices THE GROWING ROLE OF HUMAN FACTORS AND USABILITY ENGINEERING FOR MEDICAL DEVICES

whitepaper

Oct 13, 2018

Medical errors have been cited as the cause of nearly 100,000 deaths per year in the US healthcare system by the US Institute of Medicine in 1994 in its book, To err is human: Building a safer health system. According to the World Health Organization...

Read More

Bacteriophages and their applications BACTERIOPHAGES AND THEIR APPLICATIONS

whitepaper

Oct 10, 2018

Bacteriophages are ubiquitous in our world, mainly in the oceans, soil, the water and food we consume. They can be used efficiently in modern biotechnology, as well as alternatives to antibiotics for many antibiotic-resistant bacterial strains.

Read More

THE ADVANTAGE OF HOLLOW FIBER BIOREACTORS THE ADVANTAGE OF HOLLOW FIBER BIOREACTORS

whitepaper

Oct 09, 2018

It is now appreciated that conventional cell culture techniques are not the most physiologically relevant way to grow cells or the optimal way to harvest biologics for production. Cells grown on nonporous plastic dishes suffer from uneven nutrient di...

Read More

A Case for Online Water Bioburden Analyzers A CASE FOR ONLINE WATER BIOBURDEN ANALYZERS

whitepaper

Oct 06, 2018

An industry workgroup has identified the benefits of a new class of instrumentation for real-time water bioburden analysis, noting its “potential to improve pharmaceutical water system operations, reduce costs, and ensure water quality.” ...

Read More

The interoperability opportunity: Improving healthcare with an end-to-end enterprise strategy THE INTEROPERABILITY OPPORTUNITY: IMPROVING HEALTHCARE WITH AN END-TO-END ENTERPRISE STRATEGY

whitepaper

Oct 04, 2018

Picture a single patient in a single ICU anywhere in this country. Ten devices are connected to that single patient, and each device is producing data every few seconds or minutes. What can this one patient and the data he or she generates tell us ab...

Read More

The Patient Engagement Dilemma THE PATIENT ENGAGEMENT DILEMMA

whitepaper

Oct 04, 2018

In an effort to reduce costs and improve patient clinical outcomes, the Affordable Care Act (ACA) in the US has been instrumental in driving widespread changes in the healthcare delivery system. These changes have caused a cultural shift in the ...

Read More

Driving Sales Behavior With Non-Cash Rewards DRIVING SALES BEHAVIOR WITH NON-CASH REWARDS

whitepaper

Oct 03, 2018

In the end, you need to be rewarding your sales reps with more than just money if you want to keep them motivated and if you want your sales compensation plan to deliver on its promises.

Read More

Change the sales rep experience, improve the customer experience CHANGE THE SALES REP EXPERIENCE, IMPROVE THE CUSTOMER EXPERIENCE

whitepaper

Oct 03, 2018

The first CRM launch truly changed the way sales were managed. We went from tracking customers on spreadsheets (and even in rolodexes) to tracking them and their attendant opportunities with software. It wasn’t long before reps started to feel ...

Read More

Pipeline Management and Forecasting Are Key to Improving the Sales Experience PIPELINE MANAGEMENT AND FORECASTING ARE KEY TO IMPROVING THE SALES EXPERIENCE

whitepaper

Oct 03, 2018

Let’s explore some of the current processes around pipeline management and forecasting and how they can be improved.

Read More

Cancer Cell Culture CANCER CELL CULTURE

whitepaper

Oct 02, 2018

Cell culture is practiced extensively throughout the world today. The techniques required to allow cells to grow and be maintained outside the body have been developed throughout the 20th century. In the 50 years since the publication of the first&nb...

Read More

5 ways Artificial Intelligence is transforming healthcare operations 5 WAYS ARTIFICIAL INTELLIGENCE IS TRANSFORMING HEALTHCARE OPERATIONS

whitepaper

Sep 28, 2018

While the practical applications of artificial intelligence (AI) are still being discovered, one area of AI natural language processing (NLP) is already helping advance the revenue cycle. Discover how the right NLP can support accuracy, efficiency an...

Read More

The Evolution Of Anti-Body-Drug Manufacturing THE EVOLUTION OF ANTI-BODY-DRUG MANUFACTURING

whitepaper

Sep 26, 2018

Even before the 1980s, the notion of attaching a cytotoxic agent to a tumor-specific antibody captured the collective imagination of the international drug development community. Were antibody-drug conjugates (ADCs) the magic bullets everyone was loo...

Read More

First Things First: Primary Cells in Research FIRST THINGS FIRST: PRIMARY CELLS IN RESEARCH

whitepaper

Sep 25, 2018

Primary cells are collected directly from living tissues, and as such, more closely resemble in vivo cells from a genetic and physiological perspective. This feature makes primary cells a treasure trove of potential for investigating in vivo mechanis...

Read More

Cybersecurity of medical devices CYBERSECURITY OF MEDICAL DEVICES

whitepaper

Sep 25, 2018

Increasing the connectivity of medical devices to computer networks and the convergence of technologies has exposed vulnerable devices and software applications to incidents. The need to protect patient data from cyber-attack is now well understood. ...

Read More

Improved Nucleic Acid QC with Parallel CE IMPROVED NUCLEIC ACID QC WITH PARALLEL CE

whitepaper

Sep 21, 2018

Nucleic acid quality assessment is a crucial step to the success or failure of DNA and RNA-based workflows. New methods and quality standards continually develop along with new applications. Whether for new sequencing chemistry, PCR strategy, or type...

Read More

Detection of immune checkpoint markers in peripheral blood mononuclear cell lysates with AlphaLISA DETECTION OF IMMUNE CHECKPOINT MARKERS IN PERIPHERAL BLOOD MONONUCLEAR CELL LYSATES WITH ALPHALISA

whitepaper

Sep 19, 2018

Peripheral blood mononuclear cells (PBMCs) are a heterogeneous the population of blood cells having round nuclei. They consist of monocytes, macrophages, dendritic cells and lymphocytes (T cells, B cells, and NK cells). In order to induce and upregul...

Read More

Single-Cell Multi-omics to Detect Gene Expression SINGLE-CELL MULTI-OMICS TO DETECT GENE EXPRESSION

whitepaper

Sep 19, 2018

Quantifying single-cell gene expression at the mRNA and protein level has the potential to reveal novel mechanisms of gene regulation and cell types that have been previously unappreciated in immunology. A new multi-omics technique, BD AbSeq, allows ...

Read More

Healthcare reimagined HEALTHCARE REIMAGINED

whitepaper

Sep 17, 2018

Regulatory requirements, fierce competition, and rapidly emerging technologies are creating new complexities for those operating in the healthcare sector. Many are working out how to deliver better health outcomes whilst managing evolving consumer ne...

Read More

How Beacon Health System Gained Competitive Advantage and Acquired New Patients through Telehealth HOW BEACON HEALTH SYSTEM GAINED COMPETITIVE ADVANTAGE AND ACQUIRED NEW PATIENTS THROUGH TELEHEALTH

whitepaper

Sep 15, 2018

Beacon Health System, the nonprofit parent organization of Elkhart General Hospital and Memorial Hospital of South Bend that provides care throughout Indiana and Michigan, was in search of a convenient care delivery service that could be integrated a...

Read More

Promoting Health, Preventing Disease PROMOTING HEALTH, PREVENTING DISEASE

whitepaper

Sep 12, 2018

The European Observatory on Health Systems and Policies supports and promotes evidence-based health policy-making through comprehensive and rigorous analysis of health systems in Europe. It brings together a wide range of policy-makers, academics, an...

Read More

Top Five Asian Cancers – Trends in Clinical Development TOP FIVE ASIAN CANCERS – TRENDS IN CLINICAL DEVELOPMENT

whitepaper

Sep 01, 2018

This important white paper provides an in-depth analysis of the clinical trial landscape in 10 Asian countries related to effective therapies of treatment of the five most prevalent and life-threatening Asian cancers.

Read More

Epidiolex and Epilepsy - big changes for medical marijuana EPIDIOLEX AND EPILEPSY - BIG CHANGES FOR MEDICAL MARIJUANA

whitepaper

Aug 28, 2018

With the FDA’s landmark approval of Epidiolex, a cannabidiol used to treat rare, severe pediatric epilepsies, the only obstacle to the legal sale of the drug is DEA reclassification of cannabidiol (CBD). With reclassification likely in the next...

Read More

The Evolution Of Biopharmaceutical Facility Designs THE EVOLUTION OF BIOPHARMACEUTICAL FACILITY DESIGNS

whitepaper

Aug 22, 2018

In the lifecycle of pharmaceutical and biopharmaceutical commercial manufacturing, the one constant has been changed. With the advent of modern therapeutics, large-scale commercial manufacturing became commonplace. And typically such manufacturing pr...

Read More

Perspectives and Good Practices for AI and Continuously Learning Systems in Healthcare PERSPECTIVES AND GOOD PRACTICES FOR AI AND CONTINUOUSLY LEARNING SYSTEMS IN HEALTHCARE

whitepaper

Aug 20, 2018

In the past few years, there has been a significant increase in the amount of information in healthcare, and this trend is accelerating. In addition to traditional data, such as those collected by in-vitro laboratory tests, imaging devices, physiolog...

Read More

IMMUNO-ONCOLOGY AND THE TUMOR MICROENVIRONMENT IMMUNO-ONCOLOGY AND THE TUMOR MICROENVIRONMENT

whitepaper

Aug 20, 2018

The development of cutting edge cancer treatment that uses the immune system is hinged on a better understanding of the tumor microenvironment (TME). The TME provides valuable context for understanding what subtypes of immune cells are present and ho...

Read More

Changing the future of data CHANGING THE FUTURE OF DATA

whitepaper

Aug 17, 2018

With fewer successful drug launches in the market and expiring patents, competitive intelligence, and commercial R&D decision makers are hard-pressed to make sound forecasting and planning decisions based on highly reliable data analysis. That&rs...

Read More

Backup and Disaster Recovery as a Service: Driving New Data Protection Opportunities for Healthcare Organizations BACKUP AND DISASTER RECOVERY AS A SERVICE: DRIVING NEW DATA PROTECTION OPPORTUNITIES FOR HEALTHCARE ORGANIZATIONS

whitepaper

Aug 15, 2018

The data protection market is highly dynamic, driven by new application workload deployments and cloud capabilities. Healthcare organizations are embracing cloud computing and are more willing to move certain workloads, such as IT operations, to the ...

Read More

THE FUTURE OF TECHNOLOGY IN HEALTH AND HEALTH CARE THE FUTURE OF TECHNOLOGY IN HEALTH AND HEALTH CARE

whitepaper

Aug 12, 2018

Over the course of the last century, the medical sciences have made remarkable strides in developing safer and more effective treatments, such as minimally invasive surgery and new drugs that can help mitigate the effects of diseases such as arthriti...

Read More

Measuring the concentration of Adeno-Associated Virus with multi-angle dynamic light scattering (MADLS) MEASURING THE CONCENTRATION OF ADENO-ASSOCIATED VIRUS WITH MULTI-ANGLE DYNAMIC LIGHT SCATTERING (MADLS)

whitepaper

Aug 11, 2018

For virus development and production, it is important to know the virus concentration at different stages of the process, to optimize the clone used as well as the production yields. For example, instances such as clone screening, multiplicity of inf...

Read More

Measuring the concentration of Adeno-Associated Virus with multi-angle dynamic light scattering (MADLS) MEASURING THE CONCENTRATION OF ADENO-ASSOCIATED VIRUS WITH MULTI-ANGLE DYNAMIC LIGHT SCATTERING (MADLS)

whitepaper

Aug 11, 2018

For virus development and production, it is important to know the virus concentration at different stages of the process, to optimize the clone used as well as the production yields. For example, instances such as clone screening, multiplicity of inf...

Read More

Theory of XRF, getting acquainted with the principles THEORY OF XRF, GETTING ACQUAINTED WITH THE PRINCIPLES

whitepaper

Aug 11, 2018

This booklet gives a general introduction to X-ray fluorescence (XRF) spectrometry and XRF analysis. It explains simply how a spectrometer works and how XRF analysis is done. It is intended for people new to the field of XRF analysis. Difficult mathe...

Read More

Platform approach to purification of bacterial capsular polysaccharides for vaccine production PLATFORM APPROACH TO PURIFICATION OF BACTERIAL CAPSULAR POLYSACCHARIDES FOR VACCINE PRODUCTION

whitepaper

Aug 03, 2018

Capsular polysaccharides (CPS) of encapsulated bacterial pathogens can give rise to an effective immune response in humans and are commonly used in vaccine production. This whitepaper offers an overview of modern tools and technologies that can facil...

Read More

Advantages of nanopore sequencing in microbiome research ADVANTAGES OF NANOPORE SEQUENCING IN MICROBIOME RESEARCH

whitepaper

Aug 02, 2018

The study of microbiomes the genetic material of all microorganisms in a given sample has recently attracted considerable attention, mainly due to the realization that the microbial composition of our bodies and environment can have a profound effect...

Read More

Genomics: Consumerism, Commercialization and Health Care GENOMICS: CONSUMERISM, COMMERCIALIZATION AND HEALTH CARE

whitepaper

Aug 01, 2018

To address the issues and potential of genomics in health care, the Center for Connected Medicine tapped a range of experts for insights on the opportunities, challenges, excitement, and concern surrounding genomics, as featured in this whitepaper.

Read More

Live-Cell Analysis of Cell Subsets and Heterogeneity LIVE-CELL ANALYSIS OF CELL SUBSETS AND HETEROGENEITY

whitepaper

Jul 30, 2018

Considerable heterogeneity exists in the properties and activity of individual cells, even in the simplest cell system. Analysis at the cell-by-cell level promises valuable and additional biological insight beyond which whole population measures may ...

Read More

A buyer A BUYER'S GUIDE TO PROTEIN STABILITY MEASUREMENT PLATFORMS

whitepaper

Jul 26, 2018

Most biotherapeutics are proteins or protein derivatives, and the single biggest class of biopharmaceuticals currently on the market or in development are monoclonal antibodies (mAbs). The specific binding nature of antibodies has provided the opport...

Read More

Incentive Compensation Management: Build Versus Buy INCENTIVE COMPENSATION MANAGEMENT: BUILD VERSUS BUY

whitepaper

Jul 23, 2018

Custom ICM solutions are built for you, not auditors, so they typically don’t offer visibility into actions performed over time. Auditors may lack confidence in your homegrown system, especially if they find errors or omissions. In fact, audit ...

Read More

The Three “S’s” of a Great Incentive Compensation Management System THE THREE “S’S” OF A GREAT INCENTIVE COMPENSATION MANAGEMENT SYSTEM

whitepaper

Jul 23, 2018

It all ties together. You want your sales reps to behave a certain way and close a certain amount of deals in specific verticals that match your company’s 3- and/or 5-year vision, but the systems you currently have in place to drive this behavi...

Read More

Why Enterprise CPQ Implementations Fail WHY ENTERPRISE CPQ IMPLEMENTATIONS FAIL

whitepaper

Jul 23, 2018

You’ve reached a certain point in the evolution of your company and you know it’s time to invest in a CPQ system. But buyer beware: There’s a certain misconception around CPQ systems as being plug-in devices or turnkey-ready overlay...

Read More

Moving Away from Spreadsheets: How to Know When It’s Time MOVING AWAY FROM SPREADSHEETS: HOW TO KNOW WHEN IT’S TIME

whitepaper

Jul 23, 2018

The spreadsheet conundrum... Joe Smith, sales director for Great Start-Up Number 5 Billion and Thirty-One, puts on a blindfold and reaches out blindly for something, ANYTHING, to help him organize his team’s deals and commissions. He’s ho...

Read More

Polyvinyl alcohol: Revival of a long lost polymer POLYVINYL ALCOHOL: REVIVAL OF A LONG LOST POLYMER

whitepaper

Jul 23, 2018

With target-oriented drug discovery and an increasing focus on specialized medicines, the manufacturing of final drug products is becoming more and more complex. The processing and formulation of active pharmaceutical ingredients (APIs) designed with...

Read More

Disease Diagnosis in Smart Healthcare DISEASE DIAGNOSIS IN SMART HEALTHCARE

whitepaper

Jul 22, 2018

To promote sustainable development, the smart city implies a global vision that merges artificial intelligence, big data, decision making, information and communication technology (ICT), and the internet-of-things (IoT). The aging issue is an aspect ...

Read More

ATPlite assay performance in human primary cells ATPLITE ASSAY PERFORMANCE IN HUMAN PRIMARY CELLS

whitepaper

Jul 18, 2018

One of the criteria for a compound to be considered druggable is the ability to cause or block a biological activity without toxic effects in an in vitro setting using primary human cells. As a read-out for compound-induced activity or toxicity, it i...

Read More

NEW BIOTECHNOLOGY NEW BIOTECHNOLOGY

whitepaper

Jul 13, 2018

New Biotechnology is the official journal of the European Federation o Biotechnology (EFB) and is published bimonthly. It covers both the science of biotechnology and its surrounding political, business and financial milieu. The journal publishes pee...

Read More

Mass Spectrometry For Advanced Proteomics: A Revolution In Biological Research MASS SPECTROMETRY FOR ADVANCED PROTEOMICS: A REVOLUTION IN BIOLOGICAL RESEARCH

whitepaper

Jul 11, 2018

Moving beyond its roots of merely sequencing the peptides of proteins, modern proteomics uses advanced technology to understand how structure, conformation, and post-translational modifications influence the protein's role within biological syste...

Read More

The C-Suite battle plan for cyber security attacks in healthcare THE C-SUITE BATTLE PLAN FOR CYBER SECURITY ATTACKS IN HEALTHCARE

whitepaper

Jul 08, 2018

Cybersecurity is an evolving battlefield confronting the healthcare industry with unprecedented threats. Learn how to out-maneuver your opponents and secure your healthcare facility by employing astute military-inspired strategies and cutting-edge te...

Read More

Healthcare commerce as a user-friendly experience HEALTHCARE COMMERCE AS A USER-FRIENDLY EXPERIENCE

whitepaper

Jul 07, 2018

Digitization is the absolute future of healthcare commerce so, why do only four percent of healthcare executives and leaders state they prefer automated payment plans? Outlined in this white paper, readers will learn how healthcare commerce can trans...

Read More

Digital maturity inan age of digital excitement DIGITAL MATURITY INAN AGE OF DIGITAL EXCITEMENT

whitepaper

Jul 05, 2018

It is obvious that digital technologies hold the promise of solving many besetting healthcare problems. Yet if we are too positive, we run the risk of being uncritical and perhaps exploited by unscrupulous marketing, or even marketing equally caught ...

Read More

THE HEALTHCARE EXECUTIVE’S GUIDE THE HEALTHCARE EXECUTIVE’S GUIDE

whitepaper

Jul 04, 2018

Managing the complex financial aspects of your healthcare business is a daunting task. You need a holistic, intuitive and intelligent solution that empowers you to be proactive and control costs with precision. Use this guide to make the most informe...

Read More

From plan to impact FROM PLAN TO IMPACT

whitepaper

Jul 04, 2018

Every three seconds someone in the world develops dementia. Dementia affects 50 million people, costing the global economy over US$1 trillion in 2018. By 2030, there will be an estimated 82 million people with dementia, placing an unprecedented strai...

Read More

Rise in Targeted Therapies Drives Needs for Small Volume Manufacturing RISE IN TARGETED THERAPIES DRIVES NEEDS FOR SMALL VOLUME MANUFACTURING

whitepaper

Jul 01, 2018

Biologics have experienced steady double-digit growth over the last 15 years and now comprise slightly more than a quarter of all New Molecular Entity (NME) FDA approvals. Similarly, EvaluatePharma's 2017 report on orphan drugs projects that by 2...

Read More

Opposites attract Blurring the lines between small and large molecule manufacturing OPPOSITES ATTRACT BLURRING THE LINES BETWEEN SMALL AND LARGE MOLECULE MANUFACTURING

whitepaper

Jun 28, 2018

The biopharmaceutical industry has grown impressively in recent years, with its global compound growth rate (CAGR) estimated to reach 8.5% between 2018-2023, outstripping traditional New Chemical Entity sectors1 . Emerging novel drugs show huge thera...

Read More

Microplastics: from Beach to Bench MICROPLASTICS: FROM BEACH TO BENCH

whitepaper

Jun 21, 2018

As plastics continue to enter the environment, understanding their global impact is vital to addressing microplastic pollution. Since its emergence as an environmental and potential human health threat, researchers have strived to develop tools for a...

Read More

Prostatype – White Paper PROSTATYPE – WHITE PAPER

whitepaper

Jun 20, 2018

Prostate Cancer is the most common type of cancer among men in Sweden as well as in many Western countries. However, approximately 85% of prostate cancer tumors are not rapidly progressing and will not cause clinical symptoms at the time of diagnosis...

Read More

WHAT HEALTHCARE ORGANIZATIONS SHOULD KNOW ABOUT THE GDPR WHAT HEALTHCARE ORGANIZATIONS SHOULD KNOW ABOUT THE GDPR

whitepaper

Jun 19, 2018

THE HEALTHCARE INDUSTRY IS FACING MULTIPLE CHALLENGES WHEN IT COMES TO PROTECTING SENSITIVE DATA. HERE’S AN OVERVIEW OF HOW THE RECENT EU GENERAL DATA PROTECTION REGULATIONS (GDPR) WILL AFFECT HEALTHCARE ORGANIZATIONS

Read More

The Latest Advances in Cell and Tissue Engrafted Mice THE LATEST ADVANCES IN CELL AND TISSUE ENGRAFTED MICE

whitepaper

Jun 19, 2018

Over the last century, the mouse has become the standard model organism of choice in academic laboratories and the pharmaceutical industry. The biological differences between mice and humans is a limiting factor in the translation of many discoveries...

Read More

Healthcare Data Fuels Innovation in the Classroom HEALTHCARE DATA FUELS INNOVATION IN THE CLASSROOM

whitepaper

Jun 16, 2018

The current era of healthcare technology is marked by a need for problem solvers and professionals who can work with data and the information technology used to mine it. These skills are vital to successful innovation, requiring educators to present ...

Read More

BIOTECHNOLOGY UPDATE BIOTECHNOLOGY UPDATE

whitepaper

Jun 16, 2018

This Whitepaper provides up-to-date information on activities related to biotechnology at the Organisation for Economic Co-operation and Development (OECD). It is mainly intended for OECD staff and delegates to OECD meetings who are already familiar ...

Read More

What to Look for in an Informatics Platform for Biologics R&D WHAT TO LOOK FOR IN AN INFORMATICS PLATFORM FOR BIOLOGICS R&D

whitepaper

Jun 15, 2018

In silico molecular biology tools, electronic lab notebooks, and systems for registration, sample management, workflow management, and request management form the foundation of informatics for biologics R&D. The informatics platform you adopt and...

Read More

Examples of Recently Tested Resins Suggest Wide Applicability of the Technology EXAMPLES OF RECENTLY TESTED RESINS SUGGEST WIDE APPLICABILITY OF THE TECHNOLOGY

whitepaper

Jun 14, 2018

Chromassette® is a modular chromatography technology that offers the separation capabilities of conventional chromatography plus the convenience, scalability and other benefits of a pre-packed cassette. Each Chromassette cassette is distinguished...

Read More

High-performance Rules Engine for Population Health Management HIGH-PERFORMANCE RULES ENGINE FOR POPULATION HEALTH MANAGEMENT

whitepaper

Jun 14, 2018

A business rules engine is a piece of software that manages the internal operation of a large software system based on predefined business logic. It is a specific collection of design-time and run-time software enabling an organization to define, ana...

Read More

Resistance Development to Bacteriophages Occurring
during Bacteriophage Therapy RESISTANCE DEVELOPMENT TO BACTERIOPHAGES OCCURRING DURING BACTERIOPHAGE THERAPY

whitepaper

Jun 10, 2018

Bacteriophage (phage) therapy, i.e., the use of viruses that infect bacteria as antimicrobial agents, is a promising alternative to conventional antibiotics. Indeed, resistance to antibiotics has become a major public health problem after decades of ...

Read More

Getting to First-in-Human Clinical Trials: A Make-or-Break Milestone for Small Biopharmas GETTING TO FIRST-IN-HUMAN CLINICAL TRIALS: A MAKE-OR-BREAK MILESTONE FOR SMALL BIOPHARMAS

whitepaper

Jun 07, 2018

"Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market faster. Quickly proving efficacy in first-in-human (FIH) trials is a make-or-break milestone for these cash-...

Read More

Nanotechnology NANOTECHNOLOGY

whitepaper

Jun 06, 2018

Nanotechnology is now a mature subject in terms of the basic science, and while there were many claims for what it could achieve 20 years ago when the funding in the area was beginning to ramp up, there is now much more realism in most areas of appli...

Read More

Strategies for Enhanced Treasury Operations in Healthcare STRATEGIES FOR ENHANCED TREASURY OPERATIONS IN HEALTHCARE

whitepaper

Jun 05, 2018

Every hospital and health system has a portfolio of key financial resources such as cash, credit, leverage, and invested assets that its leaders seek to deploy in a manner that balances the pursuit of growth with the organization’s risk managem...

Read More

Creating Harmonized Food Safety Processes Through Integration CREATING HARMONIZED FOOD SAFETY PROCESSES THROUGH INTEGRATION

whitepaper

Jun 05, 2018

The Food and Beverage industry is increasingly adapting to the Global Food Safety Initiative (GFSI) as its “stamp” of high quality and safety. In fact, many leading organizations today will only work with GFSI compliant suppliers. The GFS...

Read More

Enhance Precision Oncology Trial Success ENHANCE PRECISION ONCOLOGY TRIAL SUCCESS

whitepaper

Jun 04, 2018

A convergence of biological data and computing power is yielding amazing technological progress in clinical research and development. Vast amounts of data, often from disparate sources, are enabling the transformation of treatment paradigms. In many ...

Read More

Real-world evidence: Driving a new drug development paradigm in oncology REAL-WORLD EVIDENCE: DRIVING A NEW DRUG DEVELOPMENT PARADIGM IN ONCOLOGY

whitepaper

Jun 01, 2018

Evidence generation in oncology is at a key inflection point. Given the rapid pace of scientific innovation, historical approaches to drug development are increasingly burdensome, with randomized controlled trials remaining incredibly costly and time...

Read More

Bioinformatics: Data Knowledge Management With Complex Datasets BIOINFORMATICS: DATA KNOWLEDGE MANAGEMENT WITH COMPLEX DATASETS

whitepaper

May 31, 2018

With the growth of biologics showing no signs of stopping, bioinformatics continues to be a key driver when it comes to R&D development. Laboratories and their data systems are now expected to handle and manage biotechnology’s densely struc...

Read More

Exploring the hallmarks of cancer with real-time live-cell analysis EXPLORING THE HALLMARKS OF CANCER WITH REAL-TIME LIVE-CELL ANALYSIS

whitepaper

May 31, 2018

Our understanding of cancer cell biology has progressed enormously since Hanahan and Weinberg published their landmark paper describing six hallmarks of cancer in 20001. Since this time, breakthroughs in areas such as immune modulation and the tumor ...

Read More

Defending Against the Next Wave of Biosimilars DEFENDING AGAINST THE NEXT WAVE OF BIOSIMILARS

whitepaper

May 29, 2018

Biosimilar competition is disruptive and unpredictable: Not quite a true brand or a generic, it’s tough to predict what a biosimilar launch situation or go-to-market strategy will look like. We have examples to draw upon but no perfect analogue...

Read More

Outsourcing Trends in Pharma & Biotech OUTSOURCING TRENDS IN PHARMA & BIOTECH

whitepaper

May 29, 2018

Outsourcing has been labelled as one of this century’s “greatest organizational and industry structure shifts”.The general model in the pharmaceutical and biotechnology industries sees market authorization holders (MAH) rely on exte...

Read More

Long term live cell imaging in a high-content system LONG TERM LIVE CELL IMAGING IN A HIGH-CONTENT SYSTEM

whitepaper

May 29, 2018

Setting up live cell experiments can be challenging, as temperature, CO2, and evaporation need to be carefully controlled to ensure optimal cell growth conditions. In this technical note, we monitor evaporation rates, cell growth and morphology insid...

Read More

Agile Process Development In Biopharmaceuticals AGILE PROCESS DEVELOPMENT IN BIOPHARMACEUTICALS

whitepaper

May 25, 2018

The development of novel therapeutic products involves a complex network of internal departments and external partners. Different groups across Process Development organizations typically use a variety of approaches to capture, manage, analyze and re...

Read More

Patient health records and confidentiality PATIENT HEALTH RECORDS AND CONFIDENTIALITY

whitepaper

May 25, 2018

Individuals have a right to access their own health records, and in limited circumstances, access to the records of other people. The Government has made a commitment that patients should gain access to their health records within 21 days following a...

Read More

COLLABORATION IS KING: STRENGTHENING THE PAYER/PROVIDER RELATIONSHIP FOR VALUE-BASED SUCCESS COLLABORATION IS KING: STRENGTHENING THE PAYER/PROVIDER RELATIONSHIP FOR VALUE-BASED SUCCESS

whitepaper

May 25, 2018

And the move to value-based payment models is exactly that: a tremendous change that will transform the healthcare market—offering unparalleled opportunities for healthcare organizations to better manage costs while dramatically improving the h...

Read More

A Healthcare Prescription for the GCC A HEALTHCARE PRESCRIPTION FOR THE GCC

whitepaper

May 18, 2018

The healthcare industry across the Gulf Cooperation Council (GCC) is in the midst of a transition, one that will help improve the operating environment, reduce costs and increase opportunities across the value chain of the multibillion-dollar industr...

Read More

Trends in the Biosimilars Market TRENDS IN THE BIOSIMILARS MARKET

whitepaper

May 17, 2018

Despite biosimilars being available for over ten years in some markets, the biosimilars market continues to evolve. Development of biosimilars is a truly global endeavour, helped by the spread of regulatory guidance. In this white paper, we explore t...

Read More

Powerful Bioinformatic Support for Specialized Therapeutic Antibody Discovery POWERFUL BIOINFORMATIC SUPPORT FOR SPECIALIZED THERAPEUTIC ANTIBODY DISCOVERY

whitepaper

May 17, 2018

Achieving effective sequence analysis across biologic drug development their highly targeted specificity and efficacy in treating disease, monoclonal antibody (mAB) drugs have grown faster than any other class of therapeutic drugs in recent years. Ac...

Read More

Closing the gap in plant genomes CLOSING THE GAP IN PLANT GENOMES

whitepaper

May 14, 2018

According to the latest estimates, approximately 400,000 plant species are currently known to science; however, 21% of them are at risk of extinction due to factors such as climate change, habitat loss, and disease. Combatting these challenges is a k...

Read More

A new vision for comprehensive care coordination A NEW VISION FOR COMPREHENSIVE CARE COORDINATION

whitepaper

May 05, 2018

Transitioning patients between outpatient, inpatient, post-acute and home settings can be a major challenge for hospitals. For organizations participating in value-based reimbursement models, it can also be costly. This case study examines how Holyok...

Read More

HEALTHCARE IN SAUDI ARABIA HEALTHCARE IN SAUDI ARABIA

whitepaper

May 05, 2018

Investing in alternative real estate asset classes such as healthcare is a growing trend among global and local investors seeking diversification benefits as well as long term stability gave the defensive nature of the underlying income stream. In Sa...

Read More

The barriers between us and better health THE BARRIERS BETWEEN US AND BETTER HEALTH

whitepaper

May 01, 2018

The term social determinants of health (SDoH) is often used to refer to any nonmedical factors influencing health, including health-related knowledge, attitudes, beliefs or behaviors (e.g. smoking); however, SDoH also include “upstream” f...

Read More

The Present and Future State of Synthetic Biology in Canada THE PRESENT AND FUTURE STATE OF SYNTHETIC BIOLOGY IN CANADA

whitepaper

May 01, 2018

The synthetic biology community convened on March 6-7, 2018 at the “Canada Synbio 2018” Conference and Workshop as part of an ongoing effort to raise the profile and capacity of the synthetic biology community in Canada. The conference br...

Read More

ADDRESSING THE VALUE OF GENE THERAPY: ENHANCING PATIENT ACCESS TO TRANSFORMATIVE TREATMENTS ADDRESSING THE VALUE OF GENE THERAPY: ENHANCING PATIENT ACCESS TO TRANSFORMATIVE TREATMENTS

whitepaper

May 01, 2018

Gene therapy is a radical shift in our approach to disease treatment. By modifying the expression of a patient’s genes or repairing abnormal genes, gene therapy often addresses the root cause of diseases. While several new gene and cell therapi...

Read More

Can Phage replace Chemicals in Post Harvest Poultry Processing? CAN PHAGE REPLACE CHEMICALS IN POST HARVEST POULTRY PROCESSING?

whitepaper

Apr 28, 2018

Salmonella continues to be a leading cause of foodborne illness despite significant resources of time money and effort put forth by industry to combat its presence. In addition, the pressure is mounting to reduce the use of harsh chemicals due to wor...

Read More

Pesticide Use on Cannabis PESTICIDE USE ON CANNABIS

whitepaper

Apr 28, 2018

Legalized cannabis production is a rapidly growing agricultural industry. However, given that cannabis production has developed and operated in an unregulated setting various practices have been adopted that are at odds with accepted regulations rega...

Read More

VISUALIZING APOPTOSIS AS IT HAPPENS VISUALIZING APOPTOSIS AS IT HAPPENS

whitepaper

Apr 27, 2018

Apoptosis is a highly regulated and critical homeostatic process in multicellular organisms. Aberrations in this form of programmed cell death have been implicated in several pathological conditions including cancer, muscular atrophy, and autoimmune ...

Read More

Large insights into microorganisms LARGE INSIGHTS INTO MICROORGANISMS

whitepaper

Apr 27, 2018

Microorganisms are the most abundant and diverse forms of life on Earth, with an estimated 1 trillion species. They are essential components of all ecosystems and play a crucial role in health, disease and many industrial processes. The field of micr...

Read More

Microbiological Safety Testing of Cannabis MICROBIOLOGICAL SAFETY TESTING OF CANNABIS

whitepaper

Apr 20, 2018

Cannabis is increasingly becoming legal at the state level in the U.S., for either medical or recreational use. Each of these states has had to wrestle with the question of how to ensure the safety of a new product that is not covered under any exist...

Read More

Analysis of Microplastics using FTIR Imaging ANALYSIS OF MICROPLASTICS USING FTIR IMAGING

whitepaper

Apr 19, 2018

As plastics continue to enter the environment, understanding their global impact is vital to addressing microplastic pollution. Since its emergence as an environmental and potential human health threat, researchers have strived to develop tools for a...

Read More

Opening Doors to a Whole New View of Biology with Mass Spectrometry OPENING DOORS TO A WHOLE NEW VIEW OF BIOLOGY WITH MASS SPECTROMETRY

whitepaper

Apr 09, 2018

Liquid chromatography and mass spectrometry (LC-MS) have transformed the field of proteomics, enabling researchers to rapidly survey the contents of complex biological samples. However, until relatively recently it has proven challenging and labor-in...

Read More

AZ BioPac Powder Transfer: Getting Your Biologic to Market Faster AZ BIOPAC POWDER TRANSFER: GETTING YOUR BIOLOGIC TO MARKET FASTER

whitepaper

Apr 03, 2018

This white paper quantifies how one simple change can drastically reduce the time it takes to get biologics manufactured.Getting media and buffer into large-scale continuous bioprocessing has been burdensome, time-consuming and messy. Upgrading to mo...

Read More

Microbiome Modulator Drugs – The New Generation of Therapeutic MICROBIOME MODULATOR DRUGS – THE NEW GENERATION OF THERAPEUTIC

whitepaper

Mar 29, 2018

Since the discovery of the microbiome, biomedical research has been highly focused on understanding how exactly its interactions within the body contribute to health and disease, and drug development companies are very interested in understanding the...

Read More

Unleash Your Biologic UNLEASH YOUR BIOLOGIC

whitepaper

Mar 28, 2018

For biopharmaceutical quantification, it is important that these often highly concentrated biologic drugs can be measured with high accuracy in a dilution-free and batch-wise manner. While most analysis methods don’t cover all of these aspects ...

Read More

The Next Era of Genomics and Healthcare THE NEXT ERA OF GENOMICS AND HEALTHCARE

whitepaper

Mar 25, 2018

The world of healthcare is changing. Two revolutionary technologies, genomics, and blockchain, are poised to significantly improve health and well-being across the globe. Genomic medicine can enhance the understanding and treatment of as many as 7,00...

Read More

A DIGITAL TIME-LAPSE BRIGHT FIELD TECHNOLOGY TO DRIVE FASTER, HIGHER THROUGHPUT BIOANALYSIS A DIGITAL TIME-LAPSE BRIGHT FIELD TECHNOLOGY TO DRIVE FASTER, HIGHER THROUGHPUT BIOANALYSIS

whitepaper

Mar 22, 2018

The constant need to develop more rapid and cost-effective technologies for accurate, sensitive and specific detection in biological samples is a driving force behind the integration of new sample preparation tools, automation, and informatics across...

Read More

2018 Life Sciences Trends 2018 LIFE SCIENCES TRENDS

whitepaper

Mar 21, 2018

Want to learn more about 2018 Life Sciences trends? Download the Industry Trends whitepaper to:Better understand the global trends impact the life sciences industry.Understand the compliance and technology trends that affect the industry.Gain valuabl...

Read More

Is A Rapid Cooling Step Needed When Freezing Cells For Cryopreservation? IS A RAPID COOLING STEP NEEDED WHEN FREEZING CELLS FOR CRYOPRESERVATION?

whitepaper

Mar 14, 2018

Successful cell cryopreservation requires a controlled cooling rate. Cooling too rapidly or too slowly will lead to a poorer outcome. This is true because of the physical environment cells experience during cryopreservation. As ice forms in the extra...

Read More

BIOTECHNOLOGY FOR CLEAN INDUSTRIAL PRODUCTS AND PROCESSES BIOTECHNOLOGY FOR CLEAN INDUSTRIAL PRODUCTS AND PROCESSES

whitepaper

Mar 11, 2018

The report fits well into the changing framework of the OECD’s overall programme of work, which gives high priority to environmental sustainability. The 1997 publication, Sustainable Development: OECD Policy Approaches for the 21st Century, tes...

Read More

Industrial Biotechnology and Biomass Utilization INDUSTRIAL BIOTECHNOLOGY AND BIOMASS UTILIZATION

whitepaper

Mar 11, 2018

The bio-based economy can be loosely defined as consisting of those sectors that derive a majority of their market value from biological processes and/or products derived from natural materials, as opposed to products and processes associated with no...

Read More

Advantages of Raman Microscopy and Imaging in Pharmaceutical QC and R&D: an in-depth Review ADVANTAGES OF RAMAN MICROSCOPY AND IMAGING IN PHARMACEUTICAL QC AND R&D: AN IN-DEPTH REVIEW

whitepaper

Mar 09, 2018

This application note provides examples that thoroughly emphasize the benefits of Raman microscopy and imaging by the SENTERRA II when utilized in pharmaceutical applications. It offers an intuitive smooth workflow, comprehensive validation, research...

Read More

Aligning Needs & Skills for Profitable Healthcare Facilities ALIGNING NEEDS & SKILLS FOR PROFITABLE HEALTHCARE FACILITIES

whitepaper

Mar 07, 2018

Developing a new generation of workers well equipped to remake the business as new challenges arise is a huge fear of CEOs, reports industry media. It’s a very real challenge: By 2030, 10,000 people per day will reach the average retirement age...

Read More

Pharmaceutical & Biotechnology Perspectives in Liquid Process Analytics PHARMACEUTICAL & BIOTECHNOLOGY PERSPECTIVES IN LIQUID PROCESS ANALYTICS

whitepaper

Mar 05, 2018

Analytical measurements are going digital. The advantages offered by the latest, cutting-edge in-line sensors and transmitters, such as greater process quality and yield, reduced sensor maintenance, and simplified regulatory compliance, are hard to i...

Read More

Patient-Centered Healthcare via Patient Generated Health Data PATIENT-CENTERED HEALTHCARE VIA PATIENT GENERATED HEALTH DATA

whitepaper

Mar 04, 2018

Hospital and health system executives are developing and implementing new tactics to meet the healthcare industry’s core strategic need: a higher value of care at lower cost. This objective has been aided by advanced technological solutions in ...

Read More

A biotechnology company for truly personalized skincare by combining epigenetics and blockchain technology A BIOTECHNOLOGY COMPANY FOR TRULY PERSONALIZED SKINCARE BY COMBINING EPIGENETICS AND BLOCKCHAIN TECHNOLOGY

whitepaper

Mar 01, 2018

The global skincare market is broadly classified under several categories including facial cleansers, facial moisturizers, anti-aging products, and hand/body lotions. They aid in improving the skin quality by preventing wrinkles, rejuvenating cells, ...

Read More

Genetically modified plants for food use and human health an update GENETICALLY MODIFIED PLANTS FOR FOOD USE AND HUMAN HEALTH AN UPDATE

whitepaper

Mar 01, 2018

The Society periodically issues updates on reports (recent examples include updates on bovine spongiform encephalopathies and stem cells) and the following update, which is based on research published in the last three years, specifically addresses h...

Read More

NTA: Environmental Impact of Nanoparticles NTA: ENVIRONMENTAL IMPACT OF NANOPARTICLES

whitepaper

Feb 22, 2018

Despite being a relatively new technique, NTA has been recognized as showing promise as an analytical method which could furnish not just information about nanoparticle size and, equally importantly, concentration but that it could do so in complex s...

Read More

How Pharma Copes with the Pain of Developing Abuse-Deterrent Opioids HOW PHARMA COPES WITH THE PAIN OF DEVELOPING ABUSE-DETERRENT OPIOIDS

whitepaper

Feb 21, 2018

With the wide availability of generic opioid analgesics, such as oxycodone and hydromorphone, the abuse of prescription opioids has become a major public health problem in the US. Consequently, in January 2013, the FDA released draft guidance for dru...

Read More

Tale of Two Molecules TALE OF TWO MOLECULES

whitepaper

Feb 20, 2018

Two molecules, both designed to treat the same condition, both with solubility challenges. Two biopharma companies racing to be first. Biopharma A chooses to move into trials as quickly as possible, while Biopharma B decides to address broader solubi...

Read More

Importance of Metadata Cataloging in Research IMPORTANCE OF METADATA CATALOGING IN RESEARCH

whitepaper

Feb 20, 2018

Data sprawl is a systemic problem across both government and private industry. There is a struggle in most environments to understand what data exists in the environment, protect against loss of that data as employees transition, and proactively mana...

Read More

Patient Identity Management: A Dose of Patient-friendly Security for Medical Providers PATIENT IDENTITY MANAGEMENT: A DOSE OF PATIENT-FRIENDLY SECURITY FOR MEDICAL PROVIDERS

whitepaper

Feb 16, 2018

Every day, in hospitals and physician offices everywhere, healthcare providers are telling patients what’s good for them: exercise, eat better, quit smoking. No one would deny this is great advice but be getting the patient to follow it can be ...

Read More

Infusion vs. Injection: Considerations for Administering a Drug Compound Across Preclinical Research Areas INFUSION VS. INJECTION: CONSIDERATIONS FOR ADMINISTERING A DRUG COMPOUND ACROSS PRECLINICAL RESEARCH AREAS

whitepaper

Feb 15, 2018

An overview of limitations and considerations when injecting a drug compound. Information on optimizing the therapeutic index of a drug. Comparative research examples spanning a broad range of therapeutic areas that review both bolus and infusion met...

Read More

BioProcess Containers – Materials Of Construction BIOPROCESS CONTAINERS – MATERIALS OF CONSTRUCTION

whitepaper

Feb 15, 2018

Single-use technology (SUT) products are widely accepted for the manufacturing of vaccines and biologics. The increase in adoption of single-use Thermo Scientific™ BioProcess Containers (BPCs) is a result of their demonstrated performance, and ...

Read More

Manufacturing Cell Therapies Development Strategies for Commercial Vision MANUFACTURING CELL THERAPIES DEVELOPMENT STRATEGIES FOR COMMERCIAL VISION

whitepaper

Feb 13, 2018

In this white paper, Richard Grant, Global VP of Cell Therapy at Invetech, and Brian Hampson, VP of Manufacturing Development & Engineering at PCT, share their unique insights on the topic, including how to:Discover manufacturing equipment and st...

Read More

Effect of Insulin on Cell Growth and Virus Protection EFFECT OF INSULIN ON CELL GROWTH AND VIRUS PROTECTION

whitepaper

Feb 10, 2018

The goal of our project was to test insulin as a booster for cell growth and virus production. Insulin was chosen for many reasons. It is already used in cell culture, and it is approved by regulatory agencies. So this is in line with our mission to ...

Read More

Whitepaper: Bringing the Power of PCR DNA Identification to Food Safety WHITEPAPER: BRINGING THE POWER OF PCR DNA IDENTIFICATION TO FOOD SAFETY

whitepaper

Feb 01, 2018

The technology made it possible to identify the exact species of any organism, based on the tiniest bit of DNA- (or RNA-) containing residue. This is possible due to a very simple process that has now become largely automated. This whitepaper will di...

Read More

Whitepaper: Phenotypic drug discovery with high content screening WHITEPAPER: PHENOTYPIC DRUG DISCOVERY WITH HIGH CONTENT SCREENING

whitepaper

Jan 25, 2018

Reasons for phenotypic vs. target based drug discovery strategies, challenges of and maximising return of phenotypic assays.High Content Screening with detailed multiparametric assays in conjunction with powerful data visualisation and machine-learni...

Read More

Mass Spectrometric Analysis of Intact Complex Biotherapeutics MASS SPECTROMETRIC ANALYSIS OF INTACT COMPLEX BIOTHERAPEUTICS

whitepaper

Jan 20, 2018

The benefit of therapeutic antibodies is their ability to be inherently more selective than traditional small-molecule pharmaceuticals through specific binding activities, lower toxicity, and higher efficacy. And the proof of their benefits is in the...

Read More

Transforming Large Scale Genomics and Collaborative Research TRANSFORMING LARGE SCALE GENOMICS AND COLLABORATIVE RESEARCH

whitepaper

Jan 18, 2018

Discover how Intel is collaborating with the genomics community to transform large datasets into biomedical insights that accelerate personalized care, revolutionizing how genomic workflows get executed, stored, and processed at cloud scale.For years...

Read More

Solutions for the future of biomanufacturing SOLUTIONS FOR THE FUTURE OF BIOMANUFACTURING

whitepaper

Jan 15, 2018

Biomanufacturers today face new challenges to produce more efficiently, with increased quality. Many facilities have a mix of old and new equipment, often running independently on custom software. Intensified processes require a higher level of autom...

Read More

Genetic Engineering and Environmental Risk GENETIC ENGINEERING AND ENVIRONMENTAL RISK

whitepaper

Jan 10, 2018

Genetic engineering in today’s world is gaining much importance. It provides plant varieties with good agronomic characteristics, superior quality values and expressing traits of agricultural interest such as insect resistance and herbicide tol...

Read More

Achieving Operational Efficiencies for Healthcare Organizations ACHIEVING OPERATIONAL EFFICIENCIES FOR HEALTHCARE ORGANIZATIONS

whitepaper

Jan 10, 2018

Healthcare organizations are working hard to meet constituent demands for better IT services and efficiency. With huge investments in their 3-tier systems and other aging infrastructure, they are now seeking better ways to innovate and eliminate lega...

Read More

Sepsis and the Receding Grail SEPSIS AND THE RECEDING GRAIL

whitepaper

Jan 05, 2018

Sepsis is a life-threatening illness culminating in multi-organ dysfunction paired with a systemic inflammatory response. The disease burden is considerable: it is the single most expensive condition treated in hospitals, with annual costs in the US ...

Read More

Biopreservation Best Practices: A Cornerstone in the Supply Chain of Cell-based Therapies – MSC Model Case Study BIOPRESERVATION BEST PRACTICES: A CORNERSTONE IN THE SUPPLY CHAIN OF CELL-BASED THERAPIES – MSC MODEL CASE STUDY

whitepaper

Jan 02, 2018

Mesenchymal stromal cells (MSCs) are prime candidates for regenerative medicine and therapeutic applications due to both their potent immunomodulatory function and a unique ability to proliferate and differentiate into a variety of cell lineages. How...

Read More

The Effect of Geographic Breadth on Enrollment THE EFFECT OF GEOGRAPHIC BREADTH ON ENROLLMENT

whitepaper

Dec 20, 2017

Download this in-depth white paper on the effect of geographic breadth on enrollment in clinical trials of five high-interest diseases and how location, as well as the total number of countries, included affecting successful targeting of the right ma...

Read More

The Year in CRISPRs THE YEAR IN CRISPRS

whitepaper

Dec 17, 2017

The news was full of CRISPR developments in 2015. New insights into the structures and mechanisms of CRISPR systems were reported. New tools and techniques were introduced. And new applications were explored. The newest CRISPR developments usually ap...

Read More

WHITE PAPER ON CANCER CARERS WHITE PAPER ON CANCER CARERS

whitepaper

Dec 17, 2017

This White Paper is a joint collaboration between the European Cancer Patients Coalition (ECPC) and Eurocarers, aimed at presenting European policy-makers at the European Union (EU) and national level with policy recommendations for a robust policy f...

Read More

South Shore Hospital - Case Study SOUTH SHORE HOSPITAL - CASE STUDY

whitepaper

Dec 08, 2017

As South Shore Health System sought to differentiate their care strategy for new mothers, they faced the challenge of establishing a consistent message across referring physicians as well as misinformation on social media. A branded mobile app allowe...

Read More

Advanced Biotechnology Tools for Invasive Species Management ADVANCED BIOTECHNOLOGY TOOLS FOR INVASIVE SPECIES MANAGEMENT

whitepaper

Dec 06, 2017

Increasingly, genetic tools are being used to detect and solve pressing environmental, social, and health-related challenges. It is clear that investments in technology innovation can be game changing, as advances in biotechnology may provide new met...

Read More

White Paper: Patterned Illumination for Optogenetics in Cell Biology WHITE PAPER: PATTERNED ILLUMINATION FOR OPTOGENETICS IN CELL BIOLOGY

whitepaper

Dec 02, 2017

Optogenetic approaches in cell biology applications are becoming more and more ubiquitous as molecular toolkits expand. However, identifying which pattern illumination technologies to use with them may be challenging. This white paper provides an ove...

Read More

A New Pharmaceutical Commons: Transforming Drug Discovery A NEW PHARMACEUTICAL COMMONS: TRANSFORMING DRUG DISCOVERY

whitepaper

Nov 30, 2017

The Oxford Martin School at the University of Oxford is a worldleading centre of pioneering research that addresses global challenges. We invest in research that cuts across disciplines to tackle a wide range of issues such as climate change, disease...

Read More

An introduction to Next-Generation Sequencing Technology AN INTRODUCTION TO NEXT-GENERATION SEQUENCING TECHNOLOGY

whitepaper

Nov 30, 2017

DNAsequencinghascome a longway since the daysoftwo-dimensionalchromatography in the 1970s. With the advent of theSanger chain termination method1 in1977, scientistsgained the ability tosequenceDNAin a reliable, reproducible manner. Adecade later, App...

Read More

Choice Of Upstream Bioreactor Technologies For Industrial Scale Viral Manufacturing CHOICE OF UPSTREAM BIOREACTOR TECHNOLOGIES FOR INDUSTRIAL SCALE VIRAL MANUFACTURING

whitepaper

Nov 29, 2017

Gene therapy, including oncolytic viruses, where the new genetic material is introduced into the body, holds promise to cure or alleviate symptoms of many different diseases. In the last few years, the field has seen rapid growth with at least 11 dru...

Read More

Mechanical regulation of musculoskeletal system development MECHANICAL REGULATION OF MUSCULOSKELETAL SYSTEM DEVELOPMENT

whitepaper

Nov 28, 2017

During embryogenesis, the musculoskeletal system develops while containing within itself a force generator in the form of the musculature. This generator becomes functional relatively early in development, exerting an increased mechanical load on nei...

Read More

2017 Agricultural Biotechnology Report 2017 AGRICULTURAL BIOTECHNOLOGY REPORT

whitepaper

Nov 27, 2017

The Australian federal government is very supportive of biotechnology and has committed considerable long-term funding to research and development. The Australian Productivity Commission recently completed an inquiry into the regulatory burden on far...

Read More

The science of gene therapy THE SCIENCE OF GENE THERAPY

whitepaper

Nov 23, 2017

Cells are the basic building blocks of all living things. The command center of each cell is called the nucleus, and it contains chromosomes. Chromosomes are made up of DNA the body’s hereditary material.Typically, every person has 2 copies of ...

Read More

Health reform 3.0: Thriving in a permanent state of policy disruption HEALTH REFORM 3.0: THRIVING IN A PERMANENT STATE OF POLICY DISRUPTION

whitepaper

Nov 17, 2017

The death of health reform has been greatly exaggerated. Though Congress was unable to pass a comprehensive national health reform bill in 2017, many other reforms are playing out in Congress, regulatory agencies and state capitals that could profoun...

Read More

Multiplying the Value of Wearables and Patient-Generated Health Data MULTIPLYING THE VALUE OF WEARABLES AND PATIENT-GENERATED HEALTH DATA

whitepaper

Nov 08, 2017

According to one recent survey, hospitals and health systems are no longer questioning the value – or desire – for Patient-Generated Health Data (PGHD). In fact, they are demanding it. Indeed, a 2018 HIMSS Media report found that 90 perce...

Read More

Sizing up the Pregnancy and Lactation Labeling Rule SIZING UP THE PREGNANCY AND LACTATION LABELING RULE

whitepaper

Oct 30, 2017

As a strategic thought leader, Wolters Kluwer Clinical Drug Information partners with content experts to bring you the latest information on important changes in the healthcare space. This white paper is based on a presentation by Drs. Michael Schatz...

Read More

Automatic calculation of HeLa cell culture confluency AUTOMATIC CALCULATION OF HELA CELL CULTURE CONFLUENCY

whitepaper

Oct 25, 2017

To obtain the maximum efficiency of transfection and avoid using expensive reagents for nothing, the cell confluency needs to be calculate with accuracy. Today, the majority of cell biologists estimate the cell confluency in culture flasks in a subje...

Read More

THE HUMAN CELL ATLAS THE HUMAN CELL ATLAS

whitepaper

Oct 18, 2017

The Human Cell Atlas (HCA) will be made up of comprehensive reference maps of all human cells the fundamental units of life as a basis for understanding fundamental human biological processes and diagnosing, monitoring, and treating disease. It will ...

Read More

DSM Looks to Challenge Traditional Stent Graft Materials with its Dyneema Purity® Membrane DSM LOOKS TO CHALLENGE TRADITIONAL STENT GRAFT MATERIALS WITH ITS DYNEEMA PURITY® MEMBRANE

whitepaper

Oct 17, 2017

A rising global demand for more minimally invasive surgeries to treat both cardiovascular and peripheral arterial diseases are driving the market to look for new and more efficient materials to construct stent grafts used in those procedures.Download...

Read More

The Scientific Path To Cycle Development THE SCIENTIFIC PATH TO CYCLE DEVELOPMENT

whitepaper

Oct 10, 2017

Management of medication delivery through lyophilization - freeze-drying - is a crucial enabling process technology for many important parenteral drugs. Close to 50% of biopharmaceuticals, including enzymes, proteins and monoclonal antibodies, must b...

Read More

Liposome Technology LIPOSOME TECHNOLOGY

whitepaper

Oct 09, 2017

Polymun offers the development of liposomal formulations for all kinds of pharmaceutically active ingredients and vaccine antigens. A broad spectrum of analytical methods has been established for this purpose. Polymun produces GMP material including ...

Read More

Where Compassion and Technology Meet: Children’s Mercy WHERE COMPASSION AND TECHNOLOGY MEET: CHILDREN’S MERCY

whitepaper

Oct 01, 2017

Young patients and their caregivers who enter Children’s Mercy Adele Hall are greeted by displays of colorful characters mounted from the ceiling and walls, whimsical designs and vibrant furnishings. But there’s much more to this facility...

Read More

Human Adult Stem Cells: Their Biosafety and Current Status in Cell-based Therapy HUMAN ADULT STEM CELLS: THEIR BIOSAFETY AND CURRENT STATUS IN CELL-BASED THERAPY

whitepaper

Sep 22, 2017

Human adult stem cells have attracted considerable interest in the field of regenerative medicine in recent years. Adult stem cells include mesenchymal stem cells, neural stem cells, hematopoietic stem cells, cardiac stem cells, hepatic stem cells et...

Read More

Advancing therapeutic antibody discovery with multiplexed screening ADVANCING THERAPEUTIC ANTIBODY DISCOVERY WITH MULTIPLEXED SCREENING

whitepaper

Sep 21, 2017

In this whitepaper, IntelliCyt Corporation describe how the iQue Screener is used to perform multiplexed screens for antibody binding to either cell surface or to circulating target antigens.Antibody-based therapeutics are the fastest growing and mos...

Read More

Advantages of long reads for genome assembly ADVANTAGES OF LONG READS FOR GENOME ASSEMBLY

whitepaper

Sep 15, 2017

Over the last decade, improvements in next generation DNA sequencing technology have transformed the field of genomics, making it an essential tool in modern genetic and clinical research laboratories. The facility to sequence whole genomes or specif...

Read More

An introduction to Next-Generation Sequencing Technology AN INTRODUCTION TO NEXT-GENERATION SEQUENCING TECHNOLOGY

whitepaper

Sep 07, 2017

DNAsequencinghascome a long way since the days of two-dimensional chromatography in the 1970s. With the advent of the anger chain termination method1 in1977, scientists gained the ability tosequenceDNAin a reliable, reproducible manner. A decade late...

Read More

Antimicrobial Resistance Benchmark 2018 ANTIMICROBIAL RESISTANCE BENCHMARK 2018

whitepaper

Aug 15, 2017

The global healthcare system depends on appropriate and timely access to antimicrobials. Without antibiotics, there is no direct treatment for infections, no safe surgery, no emergency medicine. The unchecked rise of Antimicrobial Resistance (AMR) pu...

Read More

Rapid, real-time pathogen identification and antimicrobial resistance profiling RAPID, REAL-TIME PATHOGEN IDENTIFICATION AND ANTIMICROBIAL RESISTANCE PROFILING

whitepaper

Jul 11, 2017

Whether airborne or present in food and water supplies, pathogens have the potential to affect agriculture and human health profoundly. Livestock infectious diseases can have an influence on animal welfare and global food production. Crop pathogens a...

Read More

Big Data Lipidomics for Lipid Biomarker Identification and Drug Discovery BIG DATA LIPIDOMICS FOR LIPID BIOMARKER IDENTIFICATION AND DRUG DISCOVERY

whitepaper

Jul 04, 2017

Lipidomics is the large-scale study of lipids in biological systems. The analysis of large  datasets, potentially containing up to thousands of lipidomes, is a challenging endeavour.  We have established multiparametric statistical approach...

Read More

Authenticating human cell lines using the Identifiler kits and capillary electrophoresis platforms AUTHENTICATING HUMAN CELL LINES USING THE IDENTIFILER KITS AND CAPILLARY ELECTROPHORESIS PLATFORMS

whitepaper

Jul 04, 2017

The study of human diseases relies heavily on the analysis of dissociated human cell lines grown in culture. However, an increasingly acknowledged problem is that cells grown in vitro can be misidentified or become contaminated with other unrelated c...

Read More

Blockchain-enabled genomic data sharing and analysis platform BLOCKCHAIN-ENABLED GENOMIC DATA SHARING AND ANALYSIS PLATFORM

whitepaper

Jul 02, 2017

Deoxyribonucleic acid, or DNA, is a molecule that encodes the blueprint of every living organism. DNA is a chain-like molecule of variable length made of four building blocks, commonly called letters (Figure 1). The four letters of DNA are adenine (A...

Read More

STRUCTURAL VARIATION IN THE HUMAN GENOME STRUCTURAL VARIATION IN THE HUMAN GENOME

whitepaper

Jun 14, 2017

Structural variation accounts for much of the variation among human genomes. Structural variants of all types are known to cause Mendelian disease and contribute to complex disease. Learn how long-read sequencing is enabling detection of the full spe...

Read More

The evolution of clinical research in East Asia THE EVOLUTION OF CLINICAL RESEARCH IN EAST ASIA

whitepaper

Jun 06, 2017

Clinical research has become increasingly globalized and trial activity has steadily increased in East Asia, which is home to 22% of the world’s population. This analysis takes a look at how has clinical research has evolved in this region, pro...

Read More

The Paperless Future of Healthcare and Life Sciences THE PAPERLESS FUTURE OF HEALTHCARE AND LIFE SCIENCES

whitepaper

Jun 05, 2017

Your management and IT departments are driving towards tomorrow’s wholly digital world, making critical technology investments in an effort to streamline your business. Unfortunately, they often overlook a critical last step. A hospital or medi...

Read More

A Closer Look At Cannabis Testing A CLOSER LOOK AT CANNABIS TESTING

whitepaper

Jun 04, 2017

Cannabis has demonstrated health benefits since ancient times. While less than 6% of today’s studies on marijuana analyze its medical properties, publications to date indicate that cannabis shows great promise for the treatment of many diseases...

Read More

mRNA Vaccines: Disruptive Innovation in Vaccination MRNA VACCINES: DISRUPTIVE INNOVATION IN VACCINATION

whitepaper

May 25, 2017

Vaccines to prevent infectious diseases are the greatest medical innovation of all time. The CDC estimates that U.S. childhood vaccinations given in the past two decades will prevent Americans from 322 million illnesses, 21 million hospitalizations, ...

Read More

Next-Generation Sequencing Assay Validation A Practical Guide for the Clinical Genomics Laboratory NEXT-GENERATION SEQUENCING ASSAY VALIDATION A PRACTICAL GUIDE FOR THE CLINICAL GENOMICS LABORATORY

whitepaper

May 10, 2017

Next-generation sequencing (NGS) has revolutionized the field of genomics and how in vitro diagnostic (IVD) test developers, laboratories, and clinicians are diagnosing, treating, and monitoring disease. Before you can successfully launch a clinical ...

Read More

Cybersecurity in Health: Using a trusted cloud solution to help ensure data is managed, protected, private, and compliant CYBERSECURITY IN HEALTH: USING A TRUSTED CLOUD SOLUTION TO HELP ENSURE DATA IS MANAGED, PROTECTED, PRIVATE, AND COMPLIANT

whitepaper

May 09, 2017

Too many organizations don’t realize how sophisticated cyberattacks have become. Hackers are no longer mischievous high school kids hiding in their parents’ basements. They are well organized, with tools in their arsenals that include eas...

Read More

Addressing the challenges of metagenomics for environmental and clinical research ADDRESSING THE CHALLENGES OF METAGENOMICS FOR ENVIRONMENTAL AND CLINICAL RESEARCH

whitepaper

Apr 19, 2017

The genomic analysis of multiple organisms obtained from a single sample commonly referred to as “metagenomics”, allows a great insight into the genetic makeup of microbial communities. Traditionally, microorganisms have been studied thro...

Read More

Implementing a Clinical Data Repository and Analytics Platform in 90 Days IMPLEMENTING A CLINICAL DATA REPOSITORY AND ANALYTICS PLATFORM IN 90 DAYS

whitepaper

Apr 18, 2017

There is no doubt that the effort and cost to bring a drug successfully to market is significant. In addition, once approved, pharmaceutical and biotechnology companies face intense competitive pressures including crowded marketplaces of newly approv...

Read More

Advantages of long reads for structural variation analysis ADVANTAGES OF LONG READS FOR STRUCTURAL VARIATION ANALYSIS

whitepaper

Apr 04, 2017

The genomic variation comes in many forms, from single point mutations through too much larger structural variations. To date, the majority of genetic research has focused on single nucleotide polymorphisms (SNPs); however, it is now known that struc...

Read More

ASSESSING DRUG TARGET ASSOCIATION FROM BIOLOGICAL EVIDENCES ASSESSING DRUG TARGET ASSOCIATION FROM BIOLOGICAL EVIDENCES

whitepaper

Dec 08, 2016

The full drug target profile identification is many times a necessary step in drug development process. Recently, the move to a more holistic approach in drug discovery has resulted in the increasing use of cell-based assays to discover new biologica...

Read More

FUJITSU Integrated System PRIMEFLEX® for Hadoop: Genome Analysis FUJITSU INTEGRATED SYSTEM PRIMEFLEX® FOR HADOOP: GENOME ANALYSIS

whitepaper

Dec 04, 2016

FUJITSU Integrated System PRIMEFLEX for Hadoop offers end-to-end integration from strategic consulting to use case development and implementation services for specific customer needs. Read how PRIMEFLEX for Hadoop is making an impact on The German Ca...

Read More

Machine Learning, Artificial Intelligence, and Systems Biology: A New Way to Interrogate MACHINE LEARNING, ARTIFICIAL INTELLIGENCE, AND SYSTEMS BIOLOGY: A NEW WAY TO INTERROGATE

whitepaper

Dec 01, 2016

Remarkable innovations in the technologies that generate ‘omics data have swiftly created such profound efficiencies that the cost of next-generation sequencing (NGS) has fallen below $1,000 per genome. This has led to the creation of vast amou...

Read More

THERAPEUTIC GENE EDITING: THERAPEUTIC GENE EDITING:

whitepaper

Nov 21, 2016

Gene editing* is a process that repairs or changes a gene. Medical researchers are exploring ways to use gene editing to treat or prevent human diseases. According to a recent public opinion survey, Americans are both excited and concerned about this...

Read More

Whitepaper: Discriminating copy number variation from heterogeneous samples using the S3™ Cell Sorter and the QX200™ Droplet Digital™ PCR System WHITEPAPER: DISCRIMINATING COPY NUMBER VARIATION FROM HETEROGENEOUS SAMPLES USING THE S3™ CELL SORTER AND THE QX200™ DROPLET DIGITAL™ PCR SYSTEM

whitepaper

Nov 01, 2016

Many biological samples are composed of mixtures of physiologically different cell types. These include stem cell cultures, tumor samples, and blood.Understanding the genetic makeup of a subpopulation within these samples may provide valuable clues a...

Read More

Beyond borders 2016: Biotech financing BEYOND BORDERS 2016: BIOTECH FINANCING

whitepaper

Oct 20, 2016

The poet and author Robert Louis Stevenson famously advised: “Don’t judge each day by the harvest you reap, but by the seeds you plant.” These are wise words, especially so in today’s uncertain financial climate. Whether large...

Read More

Regulatory Perspectives and Considerations for Cell & Gene Therapies REGULATORY PERSPECTIVES AND CONSIDERATIONS FOR CELL & GENE THERAPIES

whitepaper

Oct 17, 2016

This whitepaper elaborates the fundamental regulatory concerns associated with the development of cell and gene therapy products, and the need for international harmonization of regulatory requirement for approval of cell and gene therapies.Finally, ...

Read More

Biosimilars BIOSIMILARS

whitepaper

Oct 01, 2016

Biotechnology refers to the application of scientific techniques using living organisms or their parts to make or modify plants, animals, microorganisms or environment to enhance their performance and values. In the recent years biotechnology has eme...

Read More

A technical guide to identifying miRNA normalizers using TaqMan Advanced miRNA Assays A TECHNICAL GUIDE TO IDENTIFYING MIRNA NORMALIZERS USING TAQMAN ADVANCED MIRNA ASSAYS

whitepaper

Aug 26, 2016

MicroRNAs (miRNAs) represent a class of regulatory biomolecules with roles in diverse processes such as cell proliferation, differentiation, apoptosis, and oncogenesis [1]. In recent years, technological advances in research tools including qPCR, mic...

Read More

Five Ways to Streamline Building Manufacturing Systems for Biotech and Pharmaceutical Industries FIVE WAYS TO STREAMLINE BUILDING MANUFACTURING SYSTEMS FOR BIOTECH AND PHARMACEUTICAL INDUSTRIES

whitepaper

May 12, 2016

Today’s biotech and pharmaceutical production facilities must drive faster times to market and greater profitability for new products by boosting production yields and accelerating commercialization and scaling of capacityRising healthcare dema...

Read More

Synthetic Biology: The Future is Now SYNTHETIC BIOLOGY: THE FUTURE IS NOW

whitepaper

May 01, 2016

Biotechnology and specifically Synthetic Biology (SynBio) is evolving at lightning speed. SynBio makes it possible to engineer life from the ground up (allowing the formation of organisms with genetic code (DNA) not found in the natural world) and to...

Read More

2017 TRENDS IN BIOSIMILARS REPORT 2017 TRENDS IN BIOSIMILARS REPORT

whitepaper

Mar 01, 2016

Over the past several years, the U.S. healthcare system has experienced seismic shifts. We have witnessed transformations in coverage, care delivery, new technologies and outcomes-based reimbursement. We have also seen notable growth in the U.S. bios...

Read More

Biotechnology An agent for sustainable socio-economic transformation BIOTECHNOLOGY AN AGENT FOR SUSTAINABLE SOCIO-ECONOMIC TRANSFORMATION

whitepaper

Feb 05, 2016

One of the key government departments of India credited with heralding the era of adventure and entrepreneurship in the country’s science – the Department of Biotechnology (DBT) – is entering its youthful years. Thirty, as they say,...

Read More

Whitepaper: Accelerating Biosimilar & Biobetter Drug Development: Ready-to-Use, Cell-Based Assays for Potency and Lot Release Testing WHITEPAPER: ACCELERATING BIOSIMILAR & BIOBETTER DRUG DEVELOPMENT: READY-TO-USE, CELL-BASED ASSAYS FOR POTENCY AND LOT RELEASE TESTING

whitepaper

Jan 13, 2016

This whitepaper highlights how commercial tools can reduce assay development time and enable a biologic developer to get to market or submission before competitors.With the drug industry’s expanding emphasis on biologics, the need for robust ce...

Read More

Business Development for the Biotechnology and Pharmaceutical industry BUSINESS DEVELOPMENT FOR THE BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY

whitepaper

Nov 20, 2015

What is ‘business development’? This is usually the first question I have to answer whenever I’m asked what I do for a living by people outside the pharmaceutical industry. The answers I try to give are oen tailored to the audience ...

Read More

Dialogue / Advancing Meaningful Patient Engagement in Research, Development, and Review of Drugs DIALOGUE / ADVANCING MEANINGFUL PATIENT ENGAGEMENT IN RESEARCH, DEVELOPMENT, AND REVIEW OF DRUGS

whitepaper

Sep 22, 2015

On March 2, 2015, the National Health Council (NHC) and Genetic Alliance hosted an invitation-only Dialogue Event at the offi ces of the Food and Drug Administration (FDA) in Silver Spring, Maryland, including thought leaders involved in patient enga...

Read More

Accelerating R&D in Industrial Biotechnology ACCELERATING R&D IN INDUSTRIAL BIOTECHNOLOGY

whitepaper

Jun 25, 2015

The development of industrial biotechnology is a key element of the European Commission’s strategy to reinforce the bioeconomy. This is because industrial biotechnology employs biobased catalysts, such as enzymes and microorganisms, which are e...

Read More

Executing an open innovation model: Cooperation is key to competition for biopharmaceutical companies EXECUTING AN OPEN INNOVATION MODEL: COOPERATION IS KEY TO COMPETITION FOR BIOPHARMACEUTICAL COMPANIES

whitepaper

Jun 17, 2015

Many biopharmaceutical (biopharma) companies are facing a challenging research and development (R&D) environment and increased competitive pressures. Their heavy reliance on a closed, traditional model of product development might stifle true inn...

Read More

Closing the food gap: opportunities for investment? CLOSING THE FOOD GAP: OPPORTUNITIES FOR INVESTMENT?

whitepaper

Feb 15, 2015

Mirova, the subsidiary of Natixis Asset Management devoted to Responsible Investment, offers engagement investment management that aims to combine value creation and sustainable development. Embracing a global approach to analysis, Mirova has a team ...

Read More

Venture Funding of Therapeutic Innovation VENTURE FUNDING OF THERAPEUTIC INNOVATION

whitepaper

Feb 01, 2015

Access to early-stage financing is the lifeblood of biotechnology innovation. For therapeutic-focused biotechnology companies in particular, the required capital and development timelines dwarf most other industries, making it challenging to find siz...

Read More

Whitepaper: Isolation of stably transfected fluorescent cells with the S3™ Cell Sorter WHITEPAPER: ISOLATION OF STABLY TRANSFECTED FLUORESCENT CELLS WITH THE S3™ CELL SORTER

whitepaper

Jun 17, 2014

Many fields of research, from immunology to neurobiology, require the isolation of cells based on extracellular or intracellular phenotypes. A way to accomplish this with exquisite accuracy is through fluorescence-activated cell sorting (Arun 2005, M...

Read More

Technology to the Rapid Generation of Genetically Engineered Mice TECHNOLOGY TO THE RAPID GENERATION OF GENETICALLY ENGINEERED MICE

whitepaper

Mar 27, 2014

CRISPR/Cas-based gene editing has recently emerged as a versatile technology for inducing precise genetic alterations in a number of different species, including mice and rats.Given the importance of genetically engineered mice in modeling human dise...

Read More

Uniform and Scalable EB Formation for Drug Discovery and Regenerative Medicine Applications UNIFORM AND SCALABLE EB FORMATION FOR DRUG DISCOVERY AND REGENERATIVE MEDICINE APPLICATIONS

whitepaper

Jul 20, 2012

The developmental versatility of pluripotent stem cells (PSCs) offers a powerful approach for directing cell fate, and these cells are a promising source of progenitors and terminally differentiated somatic cells for cell replacement therapy and drug...

Read More

Life sciences and biotechnology A strategy for Europe LIFE SCIENCES AND BIOTECHNOLOGY A STRATEGY FOR EUROPE

whitepaper

Aug 15, 2011

Life sciences and biotechnology are widely recognized to be, after information technology, the next wave of the knowledge-based economy, creating new opportunities for our societies and economies. They also raise important policy and societal issues ...

Read More

BIOTECHNOLOGY’S IMPACT ON DISEASES OF THE ELDERLY BIOTECHNOLOGY’S IMPACT ON DISEASES OF THE ELDERLY

whitepaper

Sep 01, 2000

“Biotechnology’s Impact on Diseases of the Elderly: A White Paper” describes the costs of these eight age-related illnesses in human and economic terms. It also examines some of the biotech medicines on the market and in development...

Read More

The Value of Biobetters THE VALUE OF BIOBETTERS

whitepaper

The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biologics are expected to account for approximately 17% of total global spending on medicines by 2016, and reach an overall market value of $200 billion to $210 billi...

Read More

2016-CCMDR-Workshop Whitepaper 2016-CCMDR-WORKSHOP WHITEPAPER

whitepaper

A research workshop dedicated to metabolic disease research, with a specific emphasis on diabetes (T1D and T2D) and obesity, was held at The University of Connecticut, Department for Cell and Genome Sciences in Farmington, Connecticut, on April 11-12...

Read More

UNLEASHING THE NEXT GENERATION OF BIOTECHNOLOGY INNOVATION UNLEASHING THE NEXT GENERATION OF BIOTECHNOLOGY INNOVATION

whitepaper

Modern biotechnology is a young industry. But in just over four decades, the scientists, researchers and entrepreneurs working in this field have firmly established themselves at the forefront of medical innovation.

Read More

Multivariate Data Analysis for Biotechnology and Bio-processing MULTIVARIATE DATA ANALYSIS FOR BIOTECHNOLOGY AND BIO-PROCESSING

whitepaper

Multivariate data analysis (MVA) and Design of Experiments (DoE) are advanced analysis techniques which enable biotech organizations to improve their data analysis and optimize operations across the product lifecycle. MVA and DoE are used in applicat...

Read More

BioSimilar BIOSIMILAR

whitepaper

Biologics have now gained significant traction in pharmaceutical industry with more than $150 Bn in global sales in 2013. 48% of sales come from 11 biologics that face loss of exclusivity over the next few years. This along with the increasing worldw...

Read More

THE 340B DRUG DISCOUNT PROGRAM THE 340B DRUG DISCOUNT PROGRAM

whitepaper

A publication of the following organizations: the Biotechnology Industry Organization (BIO), the Community Oncology Alliance (COA), the National Community Pharmacists Association (NCPA), National Patient Advocate Foundation (NPAF), the Pharmaceutical...

Read More

OTA GMO whitepaper OTA GMO WHITEPAPER

whitepaper

Genetically modified organisms (more commonly referred to as GMOs) are organisms that have been created through the application of transgenic, gene-splicing techniques that are part of biotechnology. These methods for moving genes are also referred t...

Read More

Booming Biotech BOOMING BIOTECH

whitepaper

The biotechnology industry has experienced accelerated growth in recent years. The major factor influencing this growth has been large pharmaceutical companies looking for their next blockbuster drug coupled with an aging population facing a long lis...

Read More

Embracing Innovation, Driving Growth Across Healthcare Continuum EMBRACING INNOVATION, DRIVING GROWTH ACROSS HEALTHCARE CONTINUUM

whitepaper

ASSOCHAM strongly believes that it is important to strike the balance in population's ability to pay with their desire for access to modern care and technology. This requires innovation at all levels i.e. Pharmaceutical through product developmen...

Read More

2025 Roadmap for India Biotech Industry 2025 ROADMAP FOR INDIA BIOTECH INDUSTRY

whitepaper

India’s biotechnology industry has been built on four core beliefs: entrepreneurship, innovation, developing local talent, and demonstrating high quality value based care. The country is amongst the top 12 biotech destinations in the world and ...

Read More

Risk Management Programs for the Pharmaceutical Industry RISK MANAGEMENT PROGRAMS FOR THE PHARMACEUTICAL INDUSTRY

whitepaper

The FDA oversees the quality of drug products using a two-pronged approach involving review of information submitted in applications as well as inspection of manufacturing facilities for conformance to requirements for current Good Manufacturing Prac...

Read More

Life Sciences and Biotechnology Industry Clusters in Europe LIFE SCIENCES AND BIOTECHNOLOGY INDUSTRY CLUSTERS IN EUROPE

whitepaper

Life sciences and biotechnology is a strategically important area for Europe, identified as one of the key enabling technology to strengthen Europe’s global competitiveness, economic growth and quality of life. Europe’s unified effort to ...

Read More

Trackwise EQM Software TRACKWISE EQM SOFTWARE

whitepaper

Our significant Healthcare/Pharma domain experience and technical expertise ensures increased efficiency and success in our implementations.  We continue to successfully implement TrackWise® systems for regulated and non-regulated business p...

Read More

American Society of Gene & Cell Therapy White Paper AMERICAN SOCIETY OF GENE & CELL THERAPY WHITE PAPER

whitepaper

The American Society of Gene & Cell Therapy (ASGCT) is a non-profit medical and scientific professional association comprising 1,700 researchers, clinicians, and students dedicated to the discovery and clinical application of genetic and cellular...

Read More

Overview: Malaysian Industrial Biotechnology OVERVIEW: MALAYSIAN INDUSTRIAL BIOTECHNOLOGY

whitepaper

Industrial biotechnology is the application of biological based systems and their components in the manufacture of industrial products or in the support of industrial processes. Industrial biotechnology (also referred to as “White Biotechnology...

Read More

FDA Pharmaceutical Quality Oversight FDA PHARMACEUTICAL QUALITY OVERSIGHT

whitepaper

The launch of the Center for Drug Evaluation and Research (CDER) Office of Pharmaceutical Quality (OPQ) is a milestone in FDA’s efforts to assure that quality medicines are available to the American public. As a new super-office within CDER, OP...

Read More

Navigating the Regulatory Landscape for Healthcare Product Development: Key principles and best practices NAVIGATING THE REGULATORY LANDSCAPE FOR HEALTHCARE PRODUCT DEVELOPMENT: KEY PRINCIPLES AND BEST PRACTICES

whitepaper

Developing an innovative healthcare product (a drug or a biologic, or a medical device) from the proof-of-concept stage to the marketing stage is an expensive and complex process. It involves many years of research and development work.

Read More

In Accurate, Fast Hydrogen Peroxide Decontamination Validation IN ACCURATE, FAST HYDROGEN PEROXIDE DECONTAMINATION VALIDATION

whitepaper

The pharmaceutical and medical industry suffers huge pain, high cost and poor results from conventional biological indicators. This new science of using Enzyme Indicators for measuring decontamination performance will revolutionise the industry. It&r...

Read More

ANAXOMICS’ METHODOLOGIES - UNDERSTANDING THE COMPLEXITY OF BIOLOGICAL PROCESSE ANAXOMICS’ METHODOLOGIES - UNDERSTANDING THE COMPLEXITY OF BIOLOGICAL PROCESSE

whitepaper

Biological processes arise from nature’s inherent complexity, and they involve many components connected with positive and negative feedback, sometimes with redundant circuitry, sometimes with differential pathways in different individuals, som...

Read More

PROTEIN FINGERPRINTS PAVE THE WAY FOR MICROARRAY COMPARISON PROTEIN FINGERPRINTS PAVE THE WAY FOR MICROARRAY COMPARISON

whitepaper

Anaxomics has developed a novel method of analysis for microarray data based on the generation and subsequent comparison of 2D fingerprints for each sample. Microarray results are incorporated into a protein interaction network and embedded with all ...

Read More

White Paper on India’s Biotechnology Start-up Ecosystem WHITE PAPER ON INDIA’S BIOTECHNOLOGY START-UP ECOSYSTEM

whitepaper

A preliminary study was undertaken by ABLE to understand the density of biotech start-ups (as per the definition prescribed by Start-up India policy). A key finding of the study is that the number of start-ups in the biotechnology space between Janua...

Read More

Biotech reinvented Where do you go from here? BIOTECH REINVENTED WHERE DO YOU GO FROM HERE?

whitepaper

The biotechnology industry (Biotech) is now about 30 years old – a long enough time in which to evaluate how it’s done. Unfortunately, despite some notable successes, it hasn’t completely fulfilled its promise. The business model on...

Read More

Next Generation Technology, Procedures, and Products Facilitate Biopreservation Best Practices for Cellular Therapies. NEXT GENERATION TECHNOLOGY, PROCEDURES, AND PRODUCTS FACILITATE BIOPRESERVATION BEST PRACTICES FOR CELLULAR THERAPIES.

whitepaper

The quality of procedures and products used for preparing, transporting and storing cells at cryogenic temperatures have a direct impact on post-thaw viability and functionality, as well as the consistency and reliability of biological agents from a ...

Read More

Patient Advocacy PATIENT ADVOCACY

whitepaper

Developing these relationships among all these parties is vital for advancing drug discovery and development–because Patients can’t wait. And that’s why we are so pleased to present this white paper–Patient Advocacy: An emergi...

Read More

ACCELERATING ACCELERATING

whitepaper

The Indian biotechnology industry is on the cusp of entering a new era when it can provide significant economic growth and development to the people of India and around the world. India already has many of the necessary ingredients needed in order to...

Read More

Cell Cultivation without Contamination CELL CULTIVATION WITHOUT CONTAMINATION

whitepaper

No other problem in cell culturing is as universal as microbial contamination. In order to avoidit, good sterile techniques and thorough culture handling are essential. Beyond that, the CO2 incubator plays a key role because it provides optimal growt...

Read More

Application-specific Membrane Prefilters for Highly Efficient Processes in Biopharmaceutical Production APPLICATION-SPECIFIC MEMBRANE PREFILTERS FOR HIGHLY EFFICIENT PROCESSES IN BIOPHARMACEUTICAL PRODUCTION

whitepaper

New medicines and diagnostics on the one hand and rising cost pressure as a result, for example, of the launch of generics and biosimilars on the other mean that new, highly efficient methods are required in biopharmaceutical production. In order to ...

Read More

Online Glucose | Lactate measurement in Batch and Fed-batch CHO cultivation ONLINE GLUCOSE | LACTATE MEASUREMENT IN BATCH AND FED-BATCH CHO CULTIVATION

whitepaper

During the cultivation of animal cells the monitoring of nutrients and metabolites has an important role for the controlling strategy of the cell culture. The measurement of glucose and lactate is one of the first steps during this process. The conte...

Read More

Process optimization made easy: design of experiments with multi-bioreactor system BIOSTAT® Qplus PROCESS OPTIMIZATION MADE EASY: DESIGN OF EXPERIMENTS WITH MULTI-BIOREACTOR SYSTEM BIOSTAT® QPLUS

whitepaper

Design of experiments (DoE) is one of the most important techniques for systematic planning, execution and statistical evaluation of experiments. Although a DoE investigation is executable in one bioreactor, multi-bioreactor systems designed for para...

Read More

Rapid and Precise Biosimilar Candidate Profiling by nanoDSF RAPID AND PRECISE BIOSIMILAR CANDIDATE PROFILING BY NANODSF

whitepaper

The development of biosimilars requires extensive physicochemical characterization of biosimilar candidate molecules which should match the quality profile of the reference molecule (originator). Here we use a novel method of thermal unfolding profil...

Read More

Getting the Full Picture: Predicting the Aggregation Propensity of mAbs Using Chemical and Thermal Denaturation on a Single, Fully Automated Platform GETTING THE FULL PICTURE: PREDICTING THE AGGREGATION PROPENSITY OF MABS USING CHEMICAL AND THERMAL DENATURATION ON A SINGLE, FULLY AUTOMATED PLATFORM

whitepaper

The presented data demonstrates that chemical denaturation is a feasible approach to predict the colloidal long-term stability of biologicals. Moreover, changes in G in dependence of the protein concentration can give immediate feedback whether pro...

Read More

DocuSign and 21 CFR Part 11 DOCUSIGN AND 21 CFR PART 11

whitepaper

It is the nirvana that Life Sciences organizations have been chasing for the past 30 years. The time is finally now. A digital transformation is taking place in the life sciences industry, from research laboratories to manufacturing facilities. All p...

Read More

Reducing Cycle Time with Digital Transaction Management REDUCING CYCLE TIME WITH DIGITAL TRANSACTION MANAGEMENT

whitepaper

We live in a mobile, digital era where health information is at our fingertips.
With the touch of a button, patients can see test results, track prescriptions,and sign up for clinical research. And yet it still takes over a decade to bring lif...

Read More

INVESTING IN THE AGE OF THE BIOTECH REVOLUTION INVESTING IN THE AGE OF THE BIOTECH REVOLUTION

whitepaper

This white paper series is our way of explaining the biotechnology revolution to our investors and supporters. We wanted to take subject matter that is manifestly complex, and reassemble it into a clear and accessible form. As a team of Healthcare se...

Read More

Metabolic Disease Research (CCMDR) and the Weizmann Institute of Science METABOLIC DISEASE RESEARCH (CCMDR) AND THE WEIZMANN INSTITUTE OF SCIENCE

whitepaper

A research workshop dedicated to metabolic disease research, with a specific emphasis on diabetes (T1D and T2D) and obesity, was held at The University of Connecticut, Department for Cell and Genome Sciences in Farmington, Connecticut, on April 11-12...

Read More

2016 Profie Biopharmaceutical Research Industry 2016 PROFIE BIOPHARMACEUTICAL RESEARCH INDUSTRY

whitepaper

The biopharmaceutical industry is at a pivotal time in medical discovery, which has enormous potential to further revolutionize the treatment of costly and debilitating diseases like Alzheimer’s, cancer, heart disease, and hepatitis C. Our abil...

Read More

What is Agricultural Biotechnology? WHAT IS AGRICULTURAL BIOTECHNOLOGY?

whitepaper

For about 10,000 years, farmers have been improving wild plants and animals through the selection and breeding of desirable characteristics. This breeding has resulted in the domesticated plants and animals that are commonly used in crop and livestoc...

Read More

The Benefits of Biotechnology THE BENEFITS OF BIOTECHNOLOGY

whitepaper

This report assesses the impact biotechnology is having on the global agriculture system from a community, health and environmental perspective

Read More

Transgenic crop: An environmental Assessment TRANSGENIC CROP: AN ENVIRONMENTAL ASSESSMENT

whitepaper

The environment effect of Transgenic crop  depend on characteristics organism,the environmental system in which crop is placed and skill it with managed.

Read More

FDA  Pharanaceutical Quality Oversight FDA PHARANACEUTICAL QUALITY OVERSIGHT

whitepaper

FDA oversight of drug product quality has in the past been exercised through two key functions: 1) regulatory review of drug applications and 2) inspection of facility compliance with current good manufacturing practices (CGMPs). However, data availa...

Read More

Material Issues in the Pharmaceutical Industry MATERIAL ISSUES IN THE PHARMACEUTICAL INDUSTRY

whitepaper

THE OVERVIEW of materials of construction corrosion failure mechanisms in the article “Corrosion in the Pharmaceutical Industry” in this Volume continues to be a valuable resource for information on this topic. Some trends in the availabi...

Read More

Future Trends In Pharmaceutical and Biotech Distribution FUTURE TRENDS IN PHARMACEUTICAL AND BIOTECH DISTRIBUTION

whitepaper

Today’s Pharma and Bio-Tech supply chain is more complex than ever! Multiple events occurring on a daily basis are shaping the competitive and regulatory environment in which channel members operate their business. ASP regulation is changing, a...

Read More

Creating New Value for Biopharma CREATING NEW VALUE FOR BIOPHARMA

whitepaper

The biopharma industry has primarily relied on product-led value creation. This has been driven by price and volume maximisation of innovative medicines, and operating cost base reduction. We believe an alternative focus is required to ensure value c...

Read More

Recommendations for immunoassay methods used for the detection of host antibodies against biotechnology products RECOMMENDATIONS FOR IMMUNOASSAY METHODS USED FOR THE DETECTION OF HOST ANTIBODIES AGAINST BIOTECHNOLOGY PRODUCTS

whitepaper

The LBABFG Steering Committee tasked a newly created Action Program Committee (APC) with the goal to prepare consensus “best practice” recommendations on immunoassay development and optimization, bioanalytical testing strategy, and method...

Read More

2017 global life sciences outlook 2017 GLOBAL LIFE SCIENCES OUTLOOK

whitepaper

Life sciences companies of all sizes and in all segments–pharmaceuticals, biotechnology, generics and biosimilars, medical technology, and wholesale and distribution–will continue to focus on achieving profitable and sustainable growth in...

Read More

Renaissance in Immunotherapy in South Korea RENAISSANCE IN IMMUNOTHERAPY IN SOUTH KOREA

whitepaper

In October 2016, Merck collaborated with KBioHealth New Drug Development Center (NDDC) to organize the 5th BioExcellence conference with the theme “Renaissance in Immunotherapy” in Osong, South Korea. The goal of the event was to provide ...

Read More

Compliance in the BioPharma Industry COMPLIANCE IN THE BIOPHARMA INDUSTRY

whitepaper

In the BioPharma industry, it’s becoming increasingly important that systems support the processes of the company. There are many ways in this heavily regulated industry in which a company can inadvertently step out of compliance. Honeywell bui...

Read More

BIOPHORUM OPERATIONS GROUP (BPOG) BEST PRACTICES GUIDE FOR EVALUATING LEACHABLES BIOPHORUM OPERATIONS GROUP (BPOG) BEST PRACTICES GUIDE FOR EVALUATING LEACHABLES

whitepaper

Use of single-use systems (SUS) and SUS components in clinical and commercial biopharmaceutical manufacturing has increased rapidly in recent years. Polymeric SUS components offer significant advantages over conventional (i.e. reusable) components in...

Read More

White Paper on Personalised  Medicine WHITE PAPER ON PERSONALISED MEDICINE

whitepaper

The White Paper describes the challenges in delivering personalised medicine, from the classification of disease, the need for greater investment in e-health and big data infrastructure, to calls for effective regulatory science and access mechanisms...

Read More

Advanced Biopharmaceutical Manufacturing: An Evolution
Underway ADVANCED BIOPHARMACEUTICAL MANUFACTURING: AN EVOLUTION UNDERWAY

whitepaper

The past decade has seen a significant shift in the nature of the products being manufactured and sold by the innovative biopharmaceutical (biopharma) industry. The global biopharmaceutical portfolio of today reflects increased therapeutic competitio...

Read More

Top 10 Challenges: Producing commercial cell and gene products TOP 10 CHALLENGES: PRODUCING COMMERCIAL CELL AND GENE PRODUCTS

whitepaper

The international regenerative medicines market – which includes the likes of cell therapies, gene/gene-modified cell therapy and tissue engineering – is set to climb to around $67 billion by 2020.  Alongside, discovering therapies t...

Read More

Compound and Biosample Management IT issues, Troubleshooting Guide COMPOUND AND BIOSAMPLE MANAGEMENT IT ISSUES, TROUBLESHOOTING GUIDE

whitepaper

Successful compound management and biological sample management stand as key enablers within the drug discovery process. Computerized inventory systems and sample cataloguing make the use of IT equipment and fluid collaboration between hardware and s...

Read More

A roadmap to a thriving industrial biotechnology sector in Europe. A ROADMAP TO A THRIVING INDUSTRIAL BIOTECHNOLOGY SECTOR IN EUROPE.

whitepaper

Industrial Biotechnology-derived products are projected to offer 5 significant potential for overcoming many of the socio-economic and environmental challenges facing the EU today.

Read More

Sample Preparation Technologies for Improved Peptide Quantitation Workflow. SAMPLE PREPARATION TECHNOLOGIES FOR IMPROVED PEPTIDE QUANTITATION WORKFLOW.

whitepaper

New sample preparation technologies can bring considerable benefit in terms of higher sample throughput and data quality to peptide quantitation. When these are combined with advances across the entire workflow, better quality, analysis speed, and gr...

Read More

AN OUTLOOK ON US BIOSIMILAR COMPETITION AN OUTLOOK ON US BIOSIMILAR COMPETITION

whitepaper

The pharmaceutical industry is experiencing change in ways it hasn’t ever before. On the demand side, we are seeing an aging population, increased prevalence of “Western” diseases, and a dramatic growth in global access to pharmaceu...

Read More

White Paper: Compliance with HIPAA, CLIA, dbGaP, EU Privacy, and ISO 27001 on DNAnexus WHITE PAPER: COMPLIANCE WITH HIPAA, CLIA, DBGAP, EU PRIVACY, AND ISO 27001 ON DNANEXUS

whitepaper

This White Paper summarizes how use of the DNAnexus platform supports compliance with various US and International regulations and standards. DNAnexus has a robust, audited set of policies, processes, and controls for security and privacy. Internally...

Read More

The importance of COPQ for the pharmaceutical industry THE IMPORTANCE OF COPQ FOR THE PHARMACEUTICAL INDUSTRY

whitepaper

As any senior executive within an organisation knows, the reduction of waste and, more importantly, the cost associated with that waste can have a major effect on any business. Whilst some waste is unavoidable, an executive can begin to implement pri...

Read More

Clinical Operations Comes of Age CLINICAL OPERATIONS COMES OF AGE

whitepaper

The delivery of the clinical study programme is the most costly, labour-intensive and time-consuming component of the drug development process. Delivering the clinical study programme successfully is getting harder as the operating environment has be...

Read More

Information Management: A Cornerstone for Compliance and Security in Life Sciences INFORMATION MANAGEMENT: A CORNERSTONE FOR COMPLIANCE AND SECURITY IN LIFE SCIENCES

whitepaper

The explosion of data in society has transformed the business and IT landscape. Life sciences companies need increasingly faster, smarter, more secure and easier-to-use systems to effectively manage and harness information. This White Paper covers th...

Read More

African Perspectives on Genetically Modified Crops AFRICAN PERSPECTIVES ON GENETICALLY MODIFIED CROPS

whitepaper

The use of genetically modified organisms (GMOs) to boost agricultural productivity is often touted in Washington policy circles as a potentially powerful tool for boosting agricultural productivity and reducing food insecurity in Africa. That confid...

Read More

White paper on the Transcription Factor ChIP-Seq WHITE PAPER ON THE TRANSCRIPTION FACTOR CHIP-SEQ

whitepaper

In this White Paper we present a performance analysis on the new Transcription Factor ChIP-seq tool available in CLC Genomics Workbench and CLC Genomics Server (version 7.5 and up), and in Biomedical Genomics Worbench and Server. Using an independent...

Read More

Scientific Program SCIENTIFIC PROGRAM

whitepaper

On behalf of the Greek Society of Clinical Chemistry - Clinical Biochemistry (GSCC-CB) and the Congress Organizing Committee, I would like to invite you to the 22nd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “Euro...

Read More

2017 Merck Life Science Executive Summit – Concept to Clinic: Bringing your molecule to market 2017 MERCK LIFE SCIENCE EXECUTIVE SUMMIT – CONCEPT TO CLINIC: BRINGING YOUR MOLECULE TO MARKET

whitepaper

Merck hosted its third Life Science Executive Summit – Concept to Clinic: Bringing your molecule to market, on January 12, 2017. The purpose of the event was to establish an open dialog within the biotech community and provide networking opport...

Read More

An Antitrust Review of a Bayer-Monsanto Merger AN ANTITRUST REVIEW OF A BAYER-MONSANTO MERGER

whitepaper

In this report, we review a potential merger between Bayer and Monsanto under the principal U.S. antitrust statute for mergers, section 7 of the Clayton Act. We find from the publicly-available data that a Bayer-Monsanto merger is presumptively antic...

Read More

THE MUST-HAVE COLLABORATIONS FOR SUCCESSFUL
DRUG DEVELOPMENT THE MUST-HAVE COLLABORATIONS FOR SUCCESSFUL DRUG DEVELOPMENT

whitepaper

Collaborations among academic and government researchers, pharmaceutical and biotechnology companies, regulatory agencies, and patients and their families are crucial to research and development of therapeutics for rare diseases. Industry, academic a...

Read More

UNDERSTANDING GENETICALLY ENGINEERED
ORGANISMS IN AGRICULTURE UNDERSTANDING GENETICALLY ENGINEERED ORGANISMS IN AGRICULTURE

whitepaper

In spring of 2014 the Dean of OSU’s College of  Agricultural Sciences charged a faculty  committee to review and summarize key considerations related to genetically engineered (GE) organisms. The committee chose five topics that engag...

Read More

ON CANCER-ASSOCIATED CACHEXIA ON CANCER-ASSOCIATED CACHEXIA

whitepaper

Malignant tumors have the ability to induce a chronic and systemic inflammatory environment that gives rise to cachexia. Metastatic disease can in fact be potently active at inducing cachexia, with onset occurring in the presence of remarkably little...

Read More

Securing soils for sustainable agriculture SECURING SOILS FOR SUSTAINABLE AGRICULTURE

whitepaper

Optimising Soil Chemistry for Agriculture and Resource Efficiency (OSCAR)’ was a workshop held at the Royal Society of Chemistry, Burlington House, London on 28th and 29th November 2011. It brought together leading academics, industrialists and...

Read More

2017 Introduction to Biotechnology and Pharmaceutical Industries in Taiwan, Rep. of China 2017 INTRODUCTION TO BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES IN TAIWAN, REP. OF CHINA

whitepaper

The Executive Yuan's One-Stop-Service Office for Biotechnology Industry is responsible for the resolving matters related to drug approval and other regulatory affairs, R&D and research application, technology transfer and commercialization, p...

Read More

Overview: Malaysian Healthcare Biotechnology OVERVIEW: MALAYSIAN HEALTHCARE BIOTECHNOLOGY

whitepaper

The healthcare biotechnology industry is undoubtedly a strategic investment opportunity, both from an economic as well as a social stand-point. Thanks to cutting-edge research, biotechnology companies have contributed a portfolio of products to diver...

Read More

Australia: Preferred Destination for Early Phase Clinical Trials AUSTRALIA: PREFERRED DESTINATION FOR EARLY PHASE CLINICAL TRIALS

whitepaper

Pharmaceutical and biotechnology companies are increasingly outsourcing clinical trials to contract research organizations (CROs). In 2015, the global contract CRO market generated USD31.4 billion in revenue, and is forecast to grow at a CAGR of 12.1...

Read More

White Paper prepared by The Alliance for the Prudent Use of Antibiotics (APUA) WHITE PAPER PREPARED BY THE ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS (APUA)

whitepaper

Antimicrobial agents (substances that kill or inhibit the growth of microorganisms such as bacteria, fungi, or protozoans) are common ingredients in many everyday household, personal care and consumer products. There are growing concerns about the em...

Read More

THE MUST-HAVE COLLABORATIONS FOR SUCCESSFUL DRUG DEVELOPMENT THE MUST-HAVE COLLABORATIONS FOR SUCCESSFUL DRUG DEVELOPMENT

whitepaper

Collaborations among academic and government researchers, pharmaceutical and biotechnology companies, regulatory agencies, and patients and their families are crucial to research and development of therapeutics for rare diseases. Industry, academic a...

Read More

ELISA 2.0 ELISA 2.0

whitepaper

Enzyme Linked Immunosorbent Assay (ELISA) is a method used to measure an analyte by means of an immunological reaction. ELISA was developed in the early 1970’s as a safe alternative to radioimmunoassays. Because of the relative ease of use, pot...

Read More

First Steps for Sustainable Bio/Pharma HVAC FIRST STEPS FOR SUSTAINABLE BIO/PHARMA HVAC

whitepaper

The bad news is that energy efficiency has understandably never been job one in the pharmaceutical industry. The good news is that opportunities abound for real progress as a new emphasis on sustainability grows. The author offers more than a daily d...

Read More

Tech Talk: Quality Metrics, Part 2 What Gets Measured Gets Done TECH TALK: QUALITY METRICS, PART 2 WHAT GETS MEASURED GETS DONE

whitepaper

At NSF we’re really passionate about two things. > We do our best to our best to ensure our clients continue to supply patients with the products they need. > We help you to prepare for the future, not for a world that no longer exists. W...

Read More

Biofuels a contribution to an informed discussion BIOFUELS A CONTRIBUTION TO AN INFORMED DISCUSSION

whitepaper

For more than 40 years, biofuels have been an important source of alternative energy but it was not until 5-7 years ago policies in the U.S. and other places brought about the steep increase in biofuel production. Once hailed as the one technology ca...

Read More

Jatropha curcas: Using Breeding and Biotechnology to Develop a New Alternative for Plant Oil, Biomass and Protein JATROPHA CURCAS: USING BREEDING AND BIOTECHNOLOGY TO DEVELOP A NEW ALTERNATIVE FOR PLANT OIL, BIOMASS AND PROTEIN

whitepaper

Over the course of the past seven years, SGB has succeeded in developing hybrids of Jatropha that are delivering per acre production in excess of 300 gallons of oil, 20 MT of green biomass and 0.6 MT of high quality protein per yeari . This document ...

Read More

Anaxomics’ Methodologies. Understanding the Complexity of Biological Processes ANAXOMICS’ METHODOLOGIES. UNDERSTANDING THE COMPLEXITY OF BIOLOGICAL PROCESSES

whitepaper

Biological processes arise from nature’s inherent complexity, and they involve many components connected with positive and negative feedback, sometimes with redundant circuitry, sometimes with differential pathways in different individuals, som...

Read More

Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products RECOMMENDATIONS FOR THE DESIGN AND OPTIMIZATION OF IMMUNOASSAYS USED IN THE DETECTION OF HOST ANTIBODIES AGAINST BIOTECHNOLOGY PRODUCTS

whitepaper

The primary concern with unintended humoral immunogenicity of biological products for manufacturers, regulatory agencies, clinicians and patients is whether antibodies produced by patients receiving the product result in clinical sequelae. However, t...

Read More

Profiles of New Approaches to Improving the Efficiency and Performance of Pharmaceutical Drug Development PROFILES OF NEW APPROACHES TO IMPROVING THE EFFICIENCY AND PERFORMANCE OF PHARMACEUTICAL DRUG DEVELOPMENT

whitepaper

Biopharmaceutical drug development has been experiencing one of its most productive periods in recent history. During the past decade, the total number of new chemical and biologic entities in the R&D pipeline has been rising 6% each year and now...

Read More

Biopharmaceutical industry BIOPHARMACEUTICAL INDUSTRY

whitepaper

The biopharmaceutical industry is at a pivotal time in medical discovery, which has enormous potential to further revolutionize the treatment of costly and debilitating diseases like Alzheimer’s, cancer, heart disease, and hepatitis C. Our abil...

Read More

Goodwin biotechnology GOODWIN BIOTECHNOLOGY

whitepaper

Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization (CDMO) that specializes in bioprocess development and cGMP manufacturing of biopharmaceuticals has expanded its Bioconjugation capabilities by adding a dedi...

Read More

Trashing Food Waste with Technology TRASHING FOOD WASTE WITH TECHNOLOGY

whitepaper

This lesson will provide a broad overview of agriculture including what is grown in Canada and why. Students will be introduced to the term biotechnology in preparation for CALM 2017 Live Stream Event and weigh a variety of perspectives on geneticall...

Read More

The Value of Innovation in Oncology THE VALUE OF INNOVATION IN ONCOLOGY

whitepaper

In recent years, the United States has witnessed significant progress in the fight against cancer, attributed to both earlier diagnosis and improved treatments.1 In 2014 alone, the U.S. Food and Drug Administration (FDA) approved 19 cancer medicines,...

Read More

QMS Deficiencies QMS DEFICIENCIES

whitepaper

Quality system elements have been the top 10 catogory of deficiencies found by in the U.K. by the MHRA for the last 10 years. In the U.S. the FDA believes that pharmaceutical quality System (pqs) element deficiencies are the maojor contributor t...

Read More

2015 Pharma profile 2015 PHARMA PROFILE

whitepaper

Biopharmaceutical companies make the medicines that save and improve patients’ lives every day. Patients often rely on medicines to keep their symptoms at bay and allow them to continue to work and live healthy, productive lives. Others rely on...

Read More

Combination Products: A 40 Year Regulatory Evolution COMBINATION PRODUCTS: A 40 YEAR REGULATORY EVOLUTION

whitepaper

Technological advances in healthcare products and the delivery of those products will continue to straddle the traditional boundaries of regulatory authority between the U.S. Food and Drug Administration’s (hereafter referred to as FDA or the A...

Read More

PhRMA Profile 2013 PHRMA PROFILE 2013

whitepaper

Today in America and around the world we confront daunting health care challenges. The incidence and costs of preventable and manageable chronic diseases like diabetes and asthma are growing. The medical needs of our rapidly aging population are unpr...

Read More

Intellectual property in Biotechnology INTELLECTUAL PROPERTY IN BIOTECHNOLOGY

whitepaper

Biotechnology is generally defined as “the application of science and technology to living organisms, as well parts, products and models thereof, to alter living or non-living materials for the production of knowledge, goods and services”...

Read More

YOUR REFERENCE GUIDE TO THE ANALYSIS OF
BIOPHARMACEUTICALS AND BIOMOLECULES YOUR REFERENCE GUIDE TO THE ANALYSIS OF BIOPHARMACEUTICALS AND BIOMOLECULES

whitepaper

Biotherapeutics have enormous potential to improve human health. The number of approved protein and antibody therapeutics continues to grow around the world as this important therapeutic class addresses unmet medical needs. But discovery and developm...

Read More

EvaluatePharma World Preview 2016 EVALUATEPHARMA WORLD PREVIEW 2016

whitepaper

The ninth edition of EvaluatePharma’s World Preview brings together many of our analyses to provide a top level insight, from the world’s financial markets, into the expected performance of the industry between now and 2022. Based on Eval...

Read More

ESTABLISHING THE STANDARDS IN BIOMARKER RESEARCH ESTABLISHING THE STANDARDS IN BIOMARKER RESEARCH

whitepaper

Biomarkers have the potential to encourage innovation, improve efficiency, and gain research organizations an advantage over their competitors. In this white paper, Thomson Reuters shows how the pharmaceutical industry is already beginning to rely on...

Read More

“Gene-Chain” a solution for enhancing privacy, security, and utility in genomic databases “GENE-CHAIN” A SOLUTION FOR ENHANCING PRIVACY, SECURITY, AND UTILITY IN GENOMIC DATABASES

whitepaper

How can we store genomic information more securely, so that its uses can be tracked over time, and so that donors of genomic information can both control and be rewarded for its uses in both personal and large-scale medicine and studies? The growth o...

Read More

An update on Regulatory Scenario in India AN UPDATE ON REGULATORY SCENARIO IN INDIA

whitepaper

India being one of the most populated countries with 1.3 billion people and a premier emerging economy is a key market for multinational pharmaceutical and biotech companies to launch their drug products. As a growing market, innovator drug and biote...

Read More

National Strategy for Biotechnology NATIONAL STRATEGY FOR BIOTECHNOLOGY

whitepaper

This document presents the Government’s strategy for biotechnology. The strategy has its origin in the Government’s white paper on research, Climate for Research, (Report No. 30 (2008-2009) to the Storting) which states that a balanced st...

Read More

Industrial or White Biotechnology INDUSTRIAL OR WHITE BIOTECHNOLOGY

whitepaper

Industrial or White Biotechnology is the application of biotechnology for the processing and production of chemicals, materials and energy. White biotechnology uses enzymes and micro-organisms to make products in sectors such as chemistry, food and f...

Read More

RANKING OF LOW MOISTURE FOODS IN SUPPORT OF MICROBIOLOGICAL RISK MANAGEMENT RANKING OF LOW MOISTURE FOODS IN SUPPORT OF MICROBIOLOGICAL RISK MANAGEMENT

whitepaper

Low moisture foods (LMF) are foods that are naturally low in moisture or are produced from higher moisture foods through drying or dehydration processes. The low water activity (aw) of these foods contributes to a long shelf life and has for many yea...

Read More

Making safe, affordable and abundant food a global reality MAKING SAFE, AFFORDABLE AND ABUNDANT FOOD A GLOBAL REALITY

whitepaper

A growing wave of food insecurity threatens more than 1 billion people around the world.1 Global food costs are growing to dangerous levels, reaching record highs in January 2011. And these prices are expected to persist, according to the United Nati...

Read More

Evaluating the Use of Patent Pools for Biotecnology: A Refutation to the USPTO White Paper Concerning Biotechnology Patent Pool EVALUATING THE USE OF PATENT POOLS FOR BIOTECNOLOGY: A REFUTATION TO THE USPTO WHITE PAPER CONCERNING BIOTECHNOLOGY PATENT POOL

whitepaper

Patent pools have a long and controversial history in the United States. Some laud patent pools as a way to further innovation and development in various industries. Supporters credit them for promoting development in areas where the presence of mult...

Read More

Getting SaaSy in Pharma GETTING SAASY IN PHARMA

whitepaper

The pharmaceutical industry is at the apex of major changes – from new government regulations to heightened consumerism and market saturation. Consequently, the entire industry is experiencing a strategic shift in all forms of operations includ...

Read More

White Paper on Tier-Based Testing for the Effects of
Proteinaceous Insecticidal Plant-Incorporated Protectants
on Non-Target Arthropods WHITE PAPER ON TIER-BASED TESTING FOR THE EFFECTS OF PROTEINACEOUS INSECTICIDAL PLANT-INCORPORATED PROTECTANTS ON NON-TARGET ARTHROPODS

whitepaper

The purpose of this paper is to summarize scientific and regulatory information on nontarget invertebrate testing and evaluation of new products expressing insecticidal proteins in an ecological risk assessment.

Read More

Delivering on the Potential of Biosimilar Medicines DELIVERING ON THE POTENTIAL OF BIOSIMILAR MEDICINES

whitepaper

As biologic medicines play a more significant role in patient care across a growing number of disease areas, the emergence of biosimilar medicines across Europe and in the United States brings the promise of new sources of value.

Read More

Introduction to Vaccines INTRODUCTION TO VACCINES

whitepaper

Vaccination is generally considered as one of the greatest public health achievements in industrialized countries during the 20th century, reducing morbidity and mortality from a broad range of vaccine-preventable diseases. Globally, over 5.9 million...

Read More

Research and Development: Fostering Vaccine Innovation in Canada RESEARCH AND DEVELOPMENT: FOSTERING VACCINE INNOVATION IN CANADA

whitepaper

Vaccine research and development (R&D) has been quietly undergoing a renaissance in recent years, particularly as health care authorities increasingly acknowledge the benefits and costeffectiveness of vaccination. Canada continues to make signifi...

Read More

Solutions for life sciences Satisfying the automation needs of the biotech and pharmaceutical industries SOLUTIONS FOR LIFE SCIENCES SATISFYING THE AUTOMATION NEEDS OF THE BIOTECH AND PHARMACEUTICAL INDUSTRIES

whitepaper

ABB addresses the needs of the life sciences industry, including product quality, regulatory, speed to market, cost efficiency and more. This is done with products, solutions, services and expertise that enhance productivity and energy efficiency for...

Read More

Implementing Compliant Pharmaceutical and Biotechnology Processes Using Oracle’s E-Business Suite IMPLEMENTING COMPLIANT PHARMACEUTICAL AND BIOTECHNOLOGY PROCESSES USING ORACLE’S E-BUSINESS SUITE

whitepaper

A number of suppliers to the Life Sciences sector claim to have developed applications or solutions that are ‘compliant’ to 21CFR Part 11. Many of these are in fact only partial solutions, do not address fundamental issues of data integri...

Read More

Updated Status and Perspective of Thailand on Research and Development of Modern Biotechnology and Biosafety  Regulation UPDATED STATUS AND PERSPECTIVE OF THAILAND ON RESEARCH AND DEVELOPMENT OF MODERN BIOTECHNOLOGY AND BIOSAFETY REGULATION

whitepaper

The role of agricultural sector has grown of greater importance and agro-industrial development is increasingly recognized as an important engine for economic growth. For many years Thailand has successfully utilized innovations in agricultural resea...

Read More

White Paper on Tier-Based Testing for the Effects of Proteinaceous Insecticidal Plant-Incorporated Protectants WHITE PAPER ON TIER-BASED TESTING FOR THE EFFECTS OF PROTEINACEOUS INSECTICIDAL PLANT-INCORPORATED PROTECTANTS

whitepaper

The purpose of this paper is to summarize scientific and regulatory information on nontarget invertebrate testing and evaluation of new products expressing insecticidal proteins in an ecological risk assessment. The information included provides a ge...

Read More

UV/VIS Spectrophotometry UV/VIS SPECTROPHOTOMETRY

whitepaper

Beside chemical analysis, the characterization of pure as well as mixtures of substances is achieved with physical methods. Among other techniques, such as the determination of melting point, refractive index and density, optical spectroscopy in the ...

Read More

A Case for Small Cap Investing: Biotech A CASE FOR SMALL CAP INVESTING: BIOTECH

whitepaper

In this paper, we sought to lay out the rationale for investing in small cap biotech. There are two key drivers of stock performance of small cap biotech: clinical data and acquisitions. As clinical data must be analyzed on a case-by-case basis, we h...

Read More

Food and Agricultural Biotechnology: Incorporating
Ethical Considerations FOOD AND AGRICULTURAL BIOTECHNOLOGY: INCORPORATING ETHICAL CONSIDERATIONS

whitepaper

Many of the expressed concerns about food and agricultural biotechnology are described as ethical. Decision leaders should interpret the expression of ethical concerns as a demand for competing visions of nature and the public good to be expressed in...

Read More

Industrial Biotechnology and Climate Change INDUSTRIAL BIOTECHNOLOGY AND CLIMATE CHANGE

whitepaper

Carbon dioxide (CO2) has the second-largest direct contribution to the greenhouse effect of all gases. Since the beginning of the Industrial Revolution, the burning of fossil fuels has contributed to the increase in carbon dioxide in the atmosphere.

Read More

StellARray™ Gene Expression System STELLARRAY™ GENE EXPRESSION SYSTEM

whitepaper

In this paper, we present three application examples demonstrating the utility of the StellARray™ Gene Expression System to reveal gene expression level changes in diverse biological contexts such as toxicology, cancer, and stem cell differenti...

Read More

Pharma 2020: Marketing the future which path will you take? PHARMA 2020: MARKETING THE FUTURE WHICH PATH WILL YOU TAKE?

whitepaper

The social, demographic and economic context in which the pharmaceutical industry (Pharma) operates is changing dramatically, as we noted in “Pharma 2020: The vision”, the White Paper PricewaterhouseCoopers* published in June 2007 (see si...

Read More

Democratising biotechnology?: Deliberation, participation and social regulation in a neo-liberal world DEMOCRATISING BIOTECHNOLOGY?: DELIBERATION, PARTICIPATION AND SOCIAL REGULATION IN A NEO-LIBERAL WORLD

whitepaper

There is now significant policy and academic interest in the governance of science and technology for sustainable development. In recent years this has come to include a growing emphasis on issues of public understanding of science and innovative pro...

Read More

Building  a strong  biobased  economy: finishing strong, focusing on what’s  next BUILDING A STRONG BIOBASED ECONOMY: FINISHING STRONG, FOCUSING ON WHAT’S NEXT

whitepaper

Special Edition of BioEnergy Research reviews the research accomplishments of Agriculture Research Service (ARS) and Forest Service (FS) on biomass and bioenergy.

Read More

Building The Digital Biotech Company BUILDING THE DIGITAL BIOTECH COMPANY

whitepaper

Moderna is focused exclusively on advancing messenger RNA (mRNA) medicines. Using mRNA – a fundamental component of human biology – as a drug, our medicines are sets of instructions that direct cells in the body to make proteins to preven...

Read More

Gaining Societal Acceptance of Biotechnology: The Case for Societal Engagement GAINING SOCIETAL ACCEPTANCE OF BIOTECHNOLOGY: THE CASE FOR SOCIETAL ENGAGEMENT

whitepaper

The acceptance of GMO's by society is critical in terms of the evolution and use of the technology because without it, companies have no social license to operate. But gaining societal acceptance in the new media era may pose special challenges a...

Read More

Plant biotechnology PLANT BIOTECHNOLOGY

whitepaper

Plant biotechnology is a sophisticated breeding technology that allows plant breeders to precisely introduce beneficial traits into plants. Biotech crops approved for use today have been improved to help farmers fight damaging weeds more efficiently,...